≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Cardiomyopathy, Hypertrophic obstructive

DOID EFO Endpoint Browser PheWeb

I9_CARDMYOHYP

hypertrophic cardiomyopathy: A condition in which the myocardium is hypertrophied without an obvious cause. The hypertrophy is generally asymmetric and may be associated with obstruction of the ventricular outflow tract.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — I42.1
  • Hospital discharge: ICD-9 — 4251A
  • Hospital discharge: ICD-8 — 42500
  • Cause of death: ICD-10 — I42.1
  • Cause of death: ICD-9 — 4251A
  • Cause of death: ICD-8 — 42500

2 out of 7 registries used, show all original rules.

726

4. Check minimum number of events

None

726

5. Include endpoints

None

726

6. Filter based on genotype QC (FinnGen only)

691

Control definitions (FinnGen only)

Control exclude
I9_OTHHEART

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF5
Parent code in ICD-10
I42
Name in latin
Cardiomyopathia hypertrophica obstructiva

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5095 2157 2870
Only index persons 3542 1521 2021
Unadjusted period prevalence (%)
Whole population 0.07 0.06 0.08
Only index persons 0.07 0.06 0.08
Median age at first event (years)
Whole population 59.89 63.64 56.99
Only index persons 58.98 62.46 56.35

-FinnGen-

Key figures

All Female Male
Number of individuals 691 294 397
Unadjusted period prevalence (%) 0.15 0.10 0.18
Median age at first event (years) 59.23 59.91 58.72

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
726
Matched controls
7260
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I42.1
ICD-10 Finland
Obstructive hypertrophic cardiomyopathy
+∞
307.7
668
*
I42.2
ICD-10 Finland
Other hypertrophic cardiomyopathy
+∞
307.7
347
*
XF404
NOMESCO Finland
Ambulatory ECG
44.3
307.7
246
83
201
Kela drug reimbursment
Chronic cardiac insufficiency
107.6
307.7
244
34
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
21.1
307.7
421
446
207
Kela drug reimbursment
Chronic arrhythmias
1861.6
307.7
317
*
I50.9
ICD-10 Finland
Heart failure, unspecified
112.5
307.7
283
41
I48
ICD-10 Finland
Atrial fibrillation and flutter
272.4
307.7
352
25
I42.0
ICD-10 Finland
Dilated cardiomyopathy
+∞
287.1
256
*
B01AA03
ATC
warfarin; systemic
15.4
280.1
309
333
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
630.4
270.9
252
6
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
12.7
267.0
372
553
C03DA01
ATC
spironolactone; oral
14.8
254.5
278
292
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1106.8
248.4
229
*
C01AA05
ATC
digoxin; systemic
54.7
238.6
138
31
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
+∞
234.5
212
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
944.9
220.1
205
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
9.8
215.1
383
742
C03CA01
ATC
furosemide; systemic
9.3
206.8
435
1005
C07AB07
ATC
bisoprolol; oral
11.7
195.5
589
1951
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
+∞
187.9
172
*
TFP20
NOMESCO Finland
Cardiodefibrillation
569.0
183.9
175
*
I50.0
ICD-10 Finland
Congestive heart failure
547.6
178.2
170
*
B01AF02
ATC
apixaban; oral
15.2
175.4
170
143
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
17.4
171.5
152
109
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1029.1
171.2
161
*
I50.1
ICD-10 Finland
Left ventricular failure
1668.8
144.9
136
*
C01BD01
ATC
amiodarone; systemic
542.0
139.2
134
*
XF402
NOMESCO Finland
ECG with work load test
8.6
131.3
200
308
K78
ICPC
Atrial fibrillation/flutter
30.8
129.9
87
32
I47.2
ICD-10 Finland
Ventricular tachycardia
728.6
127.5
122
*
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
151.5
110.7
115
9
I47.1
ICD-10 Finland
Supraventricular tachycardia
66.5
110.5
61
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.1
107.4
241
545
C07AA07
ATC
sotalol; systemic
22.9
107.2
80
39
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
9.7
106.4
137
170
XF640, ,
NOMESCO Finland
30.9
105.1
70
25
AN1
HP
Coronary angiography
7.2
102.7
181
322
I35.0
ICD-10 Finland
Aortic (valve) stenosis
52.4
100.4
58
12
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
151.4
100.0
104
8
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
+∞
99.3
93
*
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
13.9
97.8
95
78
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
53.0
93.7
54
11
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
509.3
92.5
90
*
I44.2
ICD-10 Finland
Atrioventricular block, complete
+∞
91.6
86
*
I50
ICD-10 Finland
Heart failure
43.0
86.1
52
13
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
227.5
80.0
81
*
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
13.1
79.4
79
67
I48.2
ICD-10 Finland
Chronic atrial fibrillation
820.6
76.8
74
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
27.9
75.8
52
20
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
401.3
74.1
73
*
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
9.8
71.8
88
101
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
70.8
473
2315
I25.1
ICD-10 Finland
Atherosclerotic heart disease
4.2
68.9
258
851
4251A
ICD-9 Finland
Cardiomyopathy, Hypertrophic obstructive cardiomyopathy
+∞
68.9
65
*
FPG32
NOMESCO Finland
Implantation of cardioverter-defibrillator with atrial and ventricular electrodes
+∞
66.7
63
*
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
6.4
63.8
117
212
I49.5
ICD-10 Finland
Sick sinus syndrome
142.5
62.0
65
5
250, ,
Kela drug reimbursment
142.5
62.0
65
5
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
+∞
61.3
58
*
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
+∞
61.3
58
*
C09AA05
ATC
ramipril; oral
3.7
61.2
287
1091
WX892
NOMESCO Finland
Monitored bed care
6.1
58.7
113
214
XFE00
NOMESCO Finland
Epicardial ultrasonography
16.9
57.7
49
31
XF400
NOMESCO Finland
ECG with 12 standard connections
4.2
57.5
193
580
GD1LA
NOMESCO Finland
GD
209.7
56.9
58
*
I49.3
ICD-10 Finland
Ventricular premature depolarization
12.3
54.8
56
49
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
+∞
53.8
51
*
I48.1
ICD-10 Finland
Persistent atrial fibrillation
151.4
53.6
56
*
C07AB02
ATC
metoprolol; systemic
3.8
53.3
215
731
127
Kela drug reimbursment
Transplant complication
15.6
53.2
47
32
K84
ICPC
Heart disease other
12.1
52.3
54
48
TFP34
NOMESCO Finland
Electrophysiological investigation
545.2
52.1
51
*
C08DA01
ATC
verapamil; systemic
9.6
50.9
62
70
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
6.4
50.5
89
154
WX872
NOMESCO Finland
Intensive care
7.7
50.0
74
106
L04AA06
ATC
mycophenolic acid; systemic
13.1
50.0
49
40
81
HP
Angiography of the heart and coronary arteries
6.2
50.0
92
166
C09DX04
ATC
valsartan and sacubitril; oral
+∞
49.5
47
*
Z2221
NOMESCO Finland
Medical doctor
3.3
49.4
280
1172
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
510.6
49.0
48
*
A12BA01
ATC
potassium chloride; oral
7.8
48.2
70
98
381
Kela drug reimbursment
Combination product containing sacubitril and valsartan
+∞
47.4
45
*
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
+∞
46.3
44
*
M04AA01
ATC
allopurinol; systemic
3.9
45.6
158
480
I49.0
ICD-10 Finland
Ventricular fibrillation and flutter
+∞
45.3
43
*
Z94.1
ICD-10 Finland
Heart transplant status
116.9
41.2
44
*
R06.0
ICD-10 Finland
Dyspnoea
3.0
40.7
251
1083
TK800
NOMESCO Finland
Hemodialysis
11.1
40.6
44
42
TFP30
NOMESCO Finland
Cathetric examination for cardiac arrythmia
419.8
40.5
40
*
L04AD02
ATC
tacrolimus; systemic
15.3
39.3
35
24
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
111.3
39.2
42
*
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
12.0
39.0
40
35
C01BA03
ATC
disopyramide; systemic
397.4
38.4
38
*
I42.8
ICD-10 Finland
Other cardiomyopathies
+∞
36.8
35
*
AP1
HP
Catheterization of the left side of the heart
14.2
36.7
34
25
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
4.5
35.9
94
230
R55
ICD-10 Finland
Syncope and collapse
3.7
35.7
129
399
R00.1
ICD-10 Finland
Bradycardia, unspecified
10.8
35.4
39
38
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
+∞
34.7
33
*
FN2EG
NOMESCO Finland
Catheter-based alcohol septal ablation
+∞
34.7
33
*
FPG96
NOMESCO Finland
Other implantation of permanent cardioverter-defibrillator
+∞
34.7
33
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.0
34.5
79
173
FP4B5
NOMESCO Finland
ECG, prolonged recording (24 h)
43.4
33.4
41
10
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
8.3
32.7
44
56
Z3231
NOMESCO Finland
Registered nurse
2.7
32.3
256
1236
TFP00
NOMESCO Finland
Temporary use of transvenous or epicardial pacemaker
91.9
32.0
35
*
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
+∞
31.5
30
*
FQA10
NOMESCO Finland
Orthotopic transplantation of heart with bicaval anastomosis
+∞
31.5
30
*
I44.1
ICD-10 Finland
Atrioventricular block, second degree
167.1
30.9
32
*
G04BE03
ATC
sildenafil; oral
8.9
30.8
39
46
71
HP
Electrophysiological Special Examination
+∞
30.4
29
*
FPH10
NOMESCO Finland
Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
30.4
29
*
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.7
30.0
224
1044
42500
ICD-8 Finland
Cardiomyopathy, Stenosis subaortae hypertrophicans
+∞
29.4
28
*
I46.0
ICD-10 Finland
Cardiac arrest with successful resuscitation
+∞
29.4
28
*
AS8
HP
Physiological arrhythmia pacemaker insertionDDD (R) S
+∞
29.4
28
*
A10BK01
ATC
dapagliflozin; oral
4.1
29.2
87
234
ZXE00
NOMESCO Finland
One hour or less
2.4
28.7
325
1831
I42
ICD-10 Finland
Cardiomyopathy
+∞
28.3
27
*
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
292.2
27.9
28
*
R07.4
ICD-10 Finland
Chest pain, unspecified
2.5
27.9
246
1236
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
6.1
27.4
49
85
AS4
HP
Physiological pacemaker insertion DDD (R)
+∞
27.3
26
*
AQ1
HP
Conventional electrophysiological examination
+∞
27.3
26
*
TFP35
NOMESCO Finland
Electroanatomical mapping
281.0
26.9
27
*
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
100.6
26.8
29
*
R4110
NOMESCO Finland
Physiotherapy
2.4
26.6
254
1318
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
26.5
169
722
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
26.5
319
1831
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.6
26.4
52
99
K77
ICPC
Heart failure
38.3
26.4
33
9
FPG40
NOMESCO Finland
Replacement of pulse generator in transvenous cardioverter-defibrillator
+∞
26.2
25
*
I34.1
ICD-10 Finland
Mitral (valve) prolapse
62.5
26.2
30
5
C07AG02
ATC
carvedilol; oral
4.3
25.5
69
172
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
25.4
150
615
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
25.2
114
403
FPJ22
NOMESCO Finland
Revision of cardioverter-defibrillator with atrial and ventricular electrodes
+∞
25.1
24
*
M10.9
ICD-10 Finland
Gout, unspecified
3.8
24.8
82
237
C01BC04
ATC
flecainide; systemic
134.6
24.8
26
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
24.3
233
1204
I44.7
ICD-10 Finland
Left bundle-branch block, unspecified
58.1
24.2
28
5
TFP46
NOMESCO Finland
Ablation treatment of atrial fibrillation
+∞
24.1
23
*
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.6
23.9
161
705
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.2
23.8
107
376
WX740
NOMESCO Finland
Nitrogen oxide therapy
247.8
23.8
24
*
C01DA14
ATC
isosorbide mononitrate; oral
2.8
23.5
138
563
ZXD05
NOMESCO Finland
Urgent procedure
2.3
23.3
234
1230
B01AE07
ATC
dabigatran etexilate; oral
7.4
23.1
34
48
TFC25
NOMESCO Finland
Transseptal catheterisation of left atrium or ventricle
+∞
23.0
22
*
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
86.3
22.8
25
*
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
237.2
22.7
23
*
TFJ02
NOMESCO Finland
Muscle biopsy of heart
+∞
22.0
21
*
FLE10
NOMESCO Finland
Myotomy or myectomy of left ventricle for outlet obstruction
+∞
22.0
21
*
I45.9
ICD-10 Finland
Conduction disorder, unspecified
82.7
21.8
24
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
7.4
21.8
32
45
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
226.5
21.7
22
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.2
21.5
94
324
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
21.0
296
1770
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.2
21.0
88
296
AP4
HP
Myocardial biopsy
+∞
20.9
20
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
20.7
188
939
D64.9
ICD-10 Finland
Anaemia, unspecified
2.9
20.5
106
402
I20.00
ICD-10 Finland
Unstable angina
5.8
20.3
38
69
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.3
19.6
29
41
ZXE20
NOMESCO Finland
More than three and less than five hours
2.6
19.6
125
529
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
4.2
19.0
53
135
TFC10
NOMESCO Finland
Catheterisation of left atrium or ventricle
8.3
18.9
25
31
42509
ICD-8 Finland
Cardiomyopathy, Unspecified
+∞
18.8
18
*
FPE40
NOMESCO Finland
Replacement of transvenous cardiac pacemaker electrode
+∞
18.8
18
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
18.4
52
134
TK810
NOMESCO Finland
Hemofiltration
25.8
18.3
25
10
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.3
18.2
160
783
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
18.1
210
1153
K80
ICPC
Cardiac arrhythmia NOS
3.6
17.9
61
179
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.8
17.9
25
33
Z2446
NOMESCO Finland
Social worker
3.4
17.8
68
215
TFP47
NOMESCO Finland
Ablation or modification of the AV-node
+∞
17.8
17
*
TFP32
NOMESCO Finland
Cathetric treatmen of cardiac arrythmia
+∞
17.8
17
*
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
4.7
17.7
42
94
AP2
HP
Catheterization of the right side of the heart
97.5
17.6
19
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.7
17.6
28
43
Z31.5
ICD-10 Finland
Genetic counselling
4.0
17.5
51
134
Z3226
NOMESCO Finland
Physiotherapist
2.3
17.2
157
780
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
17.0
233
1356
C08CA02
ATC
felodipine; oral
2.9
16.8
88
335
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.9
16.8
37
78
FPE96
NOMESCO Finland
Other implantation or replacement of transvenous cardiac pacemaker
+∞
16.7
16
*
3A064, ,
NOMESCO Finland
+∞
16.7
16
*
7AX01, ,
NOMESCO Finland
173.8
16.6
17
*
C08DB01
ATC
diltiazem; oral
3.8
16.2
50
137
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.5
16.1
58
177
ATX
HP
Other pacemaker replacement or related action, such as cord removal or replacement
+∞
15.7
15
*
FPJ24
NOMESCO Finland
Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
+∞
15.7
15
*
AS7
HP
Arrhythmia pacemaker insertion VVI (R) S
+∞
15.7
15
*
AP3
HP
Catheterization of the right and left side of the heart
+∞
15.7
15
*
1CX08, ,
NOMESCO Finland
87.0
15.6
17
*
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
22.6
15.6
22
10
TKC20
NOMESCO Finland
Catheterisation of bladder
3.1
15.4
67
230
C10AA01
ATC
simvastatin; oral
1.9
15.2
340
2317
C09AA04
ATC
perindopril; oral
3.8
15.2
48
134
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.3
15.1
58
184
R02
ICPC
Shortness of breath/dyspnoea
2.5
15.1
107
474
I47.9
ICD-10 Finland
Paroxysmal tachycardia, unspecified
32.5
14.9
19
6
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
21.6
14.7
21
10
C03AA03
ATC
hydrochlorothiazide; oral
2.8
14.7
77
293
FM1DM
NOMESCO Finland
Heart very extensive MRI examination with 3 Tesla magnet
+∞
14.6
14
*
74
HP
Initial installation of the atrial pacemaker
+∞
14.6
14
*
72
HP
Catheter ablation of arrhythmia
+∞
14.6
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
14.6
113
521
C01BA01
ATC
quinidine; oral
153.0
14.5
15
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.0
14.5
67
238
XF600
NOMESCO Finland
Bloodpressure measurement
3.3
14.0
55
177
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
14.0
149
783
ZX120
NOMESCO Finland
Intravenous
2.6
14.0
84
343
M10
ICD-10 Finland
Gout
3.6
13.8
46
133
H02AB06
ATC
prednisolone; systemic
1.8
13.8
338
2349
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.7
13.7
45
129
FPH96
NOMESCO Finland
Other removal of cardiac pacemaker or cardioverter-defibrillator
76.6
13.6
15
*
A46
ICD-10 Finland
Erysipelas
2.3
13.6
118
570
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
+∞
13.6
13
*
R03BB04
ATC
tiotropium bromide; inhalant
2.6
13.5
86
361
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.0
13.5
61
214
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.5
13.3
22
35
ZX108
NOMESCO Finland
Inhalation
14.1
13.3
22
16
XF622
NOMESCO Finland
Measurement of minute volume of heart
40.9
13.2
16
*
L04AD01
ATC
ciclosporin; systemic
6.1
13.1
23
39
N18.8
ICD-10 Finland
Other chronic renal failure
5.2
13.0
27
54
205
Kela drug reimbursment
Chronic hypertension
1.9
12.8
210
1281
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
12.8
90
396
C07AB03
ATC
atenolol; systemic
3.2
12.7
52
172
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
12.6
143
767
I20.09
ICD-10 Finland
Unstable angina
3.2
12.6
50
162
FPJ04
NOMESCO Finland
Revision of pacemaker generator with atrial and ventricular electrodes
+∞
12.5
12
*
4259X
ICD-9 Finland
Cardiomyopathy, Secondary cardiomyopathy, unspecified
+∞
12.5
12
*
FPG42
NOMESCO Finland
Replacement of electrode(s) in transvenous cardioverter-defibrillator
+∞
12.5
12
*
I41.8*D86.8
ICD-10 Finland
Sarcoid myocarditis
+∞
12.5
12
*
FXL00
NOMESCO Finland
Insertion and use of extra-, para- or intracorporeal VAD
+∞
12.5
12
*
4254A
ICD-9 Finland
Cardiomyopathy, Other primary cardiomyopathies
+∞
12.5
12
*
ARB
HP
Catheter ablation of arrhythmia: Cutiing or modification of the AV node
+∞
12.5
12
*
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
+∞
12.5
12
*
K83
ICPC
Heart valve disease NOS
132.2
12.5
13
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.8
12.4
38
104
A10BK03
ATC
empagliflozin; oral
2.4
12.3
89
397
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
5.8
12.0
22
39
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.8
11.9
62
235
A11CC03
ATC
alfacalcidol; systemic
5.5
11.9
23
43
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
11.9
54
190
E87.5
ICD-10 Finland
Hyperkalaemia
6.0
11.9
21
36
Z50.0
ICD-10 Finland
Cardiac rehabilitation
12.8
11.7
20
16
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.3
11.6
45
144
AK1
HP
HTX (heart transplant)
+∞
11.5
11
*
I48.4
ICD-10 Finland
Atypical atrial flutter
+∞
11.5
11
*
73
HP
Initial pacemaker installation
+∞
11.5
11
*
XFP02, ,
NOMESCO Finland
+∞
11.5
11
*
742, ,
NOMESCO Finland
+∞
11.5
11
*
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
+∞
11.5
11
*
FPJ00
NOMESCO Finland
Revision of pacemaker pulse generator or electrode
+∞
11.5
11
*
FM1AD
NOMESCO Finland
CT of heart
121.9
11.5
12
*
N19
ICD-10 Finland
Unspecified kidney failure
4.0
11.4
32
82
AA1AD
NOMESCO Finland
CT of head and brain
1.8
11.2
215
1369
3AC01, ,
NOMESCO Finland
13.0
11.2
19
15
B01AF01
ATC
rivaroxaban; oral
2.3
11.2
90
420
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.2
11.2
44
142
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.3
11.1
90
421
I49.8
ICD-10 Finland
Other specified cardiac arrhythmias
5.1
11.1
23
46
H03BB01
ATC
carbimazole; oral
3.7
11.0
35
98
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
44.0
10.9
13
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.5
10.9
72
307
R50.9
ICD-10 Finland
Fever, unspecified
2.1
10.9
115
598
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
5.2
10.8
22
43
G47.3
ICD-10 Finland
Sleep apnoea
1.9
10.8
171
1024
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
10.8
10.8
20
19
R04.0
ICD-10 Finland
Epistaxis
2.6
10.8
63
253
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.4
10.6
75
331
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
10.2
10.6
20
20
E05.89
ICD-10 Finland
Other thyrotoxicosis
111.6
10.4
11
*
I42.5
ICD-10 Finland
Other restrictive cardiomyopathy
+∞
10.4
10
*
FPE37
NOMESCO Finland
Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes
+∞
10.4
10
*
FPG04
NOMESCO Finland
Insertion of internal defibrillator, atrial and chamber electrode
+∞
10.4
10
*
R01.1
ICD-10 Finland
Cardiac murmur, unspecified
4.8
10.3
23
49
C02DE01, ,
ATC
13.4
10.2
17
13
R53
ICD-10 Finland
Malaise and fatigue
1.8
10.2
167
1010
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
10.2
10.1
19
19
B01AB05
ATC
enoxaparin; parenteral
1.7
10.0
220
1452
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
7.8
10.0
22
29
I25.2
ICD-10 Finland
Old myocardial infarction
2.8
9.9
51
192
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.3
9.9
38
121
J01DB01
ATC
cefalexin; oral
1.8
9.8
565
4793
J01FF01
ATC
clindamycin; systemic
1.8
9.8
186
1174
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.1
9.8
42
143
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.7
9.7
31
87
N18.0
ICD-10 Finland
End-stage renal disease
13.6
9.7
16
12
I20.90
ICD-10 Finland
Angina pectoris, unspecified
3.4
9.7
34
102
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
55.8
9.7
11
*
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.9
9.6
45
161
J01CA04
ATC
amoxicillin; systemic
1.8
9.5
549
4635
FM1CD
NOMESCO Finland
Very extensive CT of heart
101.3
9.4
10
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
101.3
9.4
10
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
9.4
303
2204
I48.3
ICD-10 Finland
Typical atrial flutter
+∞
9.4
9
*
FPH00
NOMESCO Finland
Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator
+∞
9.4
9
*
I34.9
ICD-10 Finland
Nonrheumatic mitral valve disorder, unspecified
+∞
9.4
9
*
42508
ICD-8 Finland
Cardiomyopathy, Alia definita
+∞
9.4
9
*
ASB
HP
Insertion of a biventricular physiological pacemaker DDD (R)
+∞
9.4
9
*
63
HP
Cardiac muscle biopsy
+∞
9.4
9
*
42798
ICD-8 Finland
Symptomatic heart disease, Alia arrhytmia definita
+∞
9.4
9
*
APS
HP
Ventricular septal alcohol ablation (septic vascular embolization)
+∞
9.4
9
*
TK830
NOMESCO Finland
Ultrafiltration
+∞
9.4
9
*
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
+∞
9.4
9
*
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
+∞
9.4
9
*
XF406
NOMESCO Finland
High resolution ECG
+∞
9.4
9
*
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
+∞
9.4
9
*
Z82.7
ICD-10 Finland
Family history of congenital malformations, deformations and chromosomal abnormalities
22.0
9.4
13
6
WX002
NOMESCO Finland
Sedation and analgesia
1.9
9.3
141
829
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
7.4
9.3
21
29
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.7
9.1
28
77
Z49.1
ICD-10 Finland
Extracorporeal dialysis
10.2
9.1
17
17
J01MA12
ATC
levofloxacin; systemic
1.9
9.0
136
798
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.0
9.0
109
594
XF409
NOMESCO Finland
Other special ECG
37.2
9.0
11
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
9.0
60
257
R11
ICD-10 Finland
Nausea and vomiting
2.4
9.0
65
289
A10BH05
ATC
linagliptin; oral
3.0
9.0
40
139
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
8.9
290
2106
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.8
8.9
44
162
FL1AC
NOMESCO Finland
Left cardioangiography
8.1
8.9
19
24
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
8.9
180
1155
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.5
8.9
30
88
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.1
8.8
82
406
FPW96
NOMESCO Finland
Other operation for arhythmia or disturbance of impulse propagation
50.6
8.7
10
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.2
8.6
78
382
B01AF03
ATC
edoxaban; oral
11.8
8.6
15
13
PD5BD
NOMESCO Finland
Extensive CT of aorta
10.2
8.6
16
16
I45.6
ICD-10 Finland
Pre-excitation syndrome
91.1
8.4
9
*
WX722
NOMESCO Finland
PEEP
2.9
8.4
39
139
I44.0
ICD-10 Finland
Atrioventricular block, first degree
12.9
8.4
14
11
C10AA05
ATC
atorvastatin; oral
1.6
8.4
310
2314
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.1
8.4
23
58
FM1JR
NOMESCO Finland
Heart, extensive metabolic PET with CT
+∞
8.3
8
*
I46.9
ICD-10 Finland
Cardiac arrest, unspecified
+∞
8.3
8
*
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
+∞
8.3
8
*
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
+∞
8.3
8
*
FPJ21
NOMESCO Finland
Revision of cardioverter-defibrillator with ventricular electrode
+∞
8.3
8
*
42792
ICD-8 Finland
Symptomatic heart disease, Fibrillatio auricularis
+∞
8.3
8
*
FPH20
NOMESCO Finland
Removal of epicardial pacemaker or cardioverter-defibrillator
+∞
8.3
8
*
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
+∞
8.3
8
*
R2110
NOMESCO Finland
Giving the first information
2.8
8.3
42
157
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
14.7
8.2
13
9
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.8
8.1
39
142
5AB14, ,
NOMESCO Finland
22.3
8.0
11
5
FN1CD
NOMESCO Finland
Very extensive CT of coronary arteries
22.3
8.0
11
5
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
8.0
38
137
WX730
NOMESCO Finland
Conventional respirator
7.4
8.0
18
25
C09AA02
ATC
enalapril; systemic
1.8
8.0
140
859
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
3.8
8.0
24
65
K04
ICPC
Palpitations/awareness of heart
3.2
7.9
31
100
M01AE01
ATC
ibuprofen; systemic, rectal
0.6
7.9
497
5652
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
11.0
7.8
14
13
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.9
7.8
37
134
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
15.2
7.7
12
8
C01BB02
ATC
mexiletine; systemic
45.5
7.7
9
*
C10AA03
ATC
pravastatin; oral
2.3
7.7
60
276
FN1CB
NOMESCO Finland
Coronary flow reserve measurement with pressure wire
3.8
7.7
23
62
A02BC02
ATC
pantoprazole; systemic
1.6
7.7
462
3825
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
7.7
336
2592
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.1
7.6
79
407
Y0399
ICD-8 Finland
Investigation of circulatory system
8.2
7.6
16
20
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
18.6
7.6
11
6
ZXD00
NOMESCO Finland
Emergency procedure
3.6
7.6
25
72
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.5
7.6
26
77
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
7.5
112
653
UJF92
NOMESCO Finland
Capsular endoscopy
4.3
7.5
19
45
M01AH05
ATC
etoricoxib; oral
0.6
7.5
267
3453
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
7.4
147
934
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.6
7.4
43
173
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.0
7.3
31
105
FME20
NOMESCO Finland
Transvenous aortic valve replacement via femoral artery
+∞
7.3
7
*
FJA00
NOMESCO Finland
Biopsy of right ventricle
+∞
7.3
7
*
FXM00
NOMESCO Finland
Removal of extra-, para- or intracorporeal VAD
+∞
7.3
7
*
WX902
NOMESCO Finland
External defibrillation of heart
+∞
7.3
7
*
4271A
ICD-9 Finland
Cardiac dysrhythmias, Paroxysmal ventricular tachycardia
+∞
7.3
7
*
FKC96
NOMESCO Finland
Other repair of mitral valve for insufficiency
+∞
7.3
7
*
I42.4
ICD-10 Finland
Endocardial fibroelastosis
+∞
7.3
7
*
AS2
HP
Ventricular pacemaker insertion VVI (R)
+∞
7.3
7
*
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
+∞
7.3
7
*
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
+∞
7.3
7
*
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
+∞
7.3
7
*
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.3
7.2
52
232
FP3A5
NOMESCO Finland
ECG with work load test
30.3
7.2
9
*
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
12.2
7.1
12
10
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
7.1
194
1339
R60.0
ICD-10 Finland
Localized oedema
1.9
7.0
89
492
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.5
7.0
24
71
N05BA01
ATC
diazepam; systemic, rectal
1.9
7.0
91
508
UJF32
NOMESCO Finland
Coloscopy
1.6
6.9
183
1250
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.4
6.9
48
211
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
3.7
6.8
21
58
J81
ICD-10 Finland
Pulmonary oedema
40.4
6.8
8
*
62
HP
Catheterization and pressure measurement of the right side of the heart
40.4
6.8
8
*
WX882
NOMESCO Finland
High dependency care
3.3
6.8
25
78
L04AX01
ATC
azathioprine; systemic
2.9
6.7
30
105
WX402
NOMESCO Finland
General anaesthesia
1.7
6.7
149
974
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.1
6.7
27
89
D86.0
ICD-10 Finland
Sarcoidosis of lung
6.5
6.7
16
25
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
4.1
6.7
18
45
D86.8
ICD-10 Finland
Sarcoidosis of other and combined sites
10.1
6.5
12
12
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
10.1
6.5
12
12
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
70.5
6.4
7
*
I47.0
ICD-10 Finland
Re-entry ventricular arrhythmia
70.5
6.4
7
*
2BD01, ,
NOMESCO Finland
70.5
6.4
7
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
70.5
6.4
7
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
70.5
6.4
7
*
N17.8
ICD-10 Finland
Other acute renal failure
7.5
6.4
14
19
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
6.4
229
1674
A10AC01
ATC
insulin (human); parenteral
2.2
6.3
52
245
61
HP
Catheterization and pressure measurement of the left side of the heart
5.6
6.3
17
31
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
11.1
6.3
11
10
TFP52
NOMESCO Finland
Ablation treatment of ventricular tachycardia due to structural heart defect
+∞
6.3
6
*
42700
ICD-8 Finland
Symptomatic heart disease, Congestive heart failure
+∞
6.3
6
*
TFP40
NOMESCO Finland
Ablation treatment for a-v node re-entry activation
+∞
6.3
6
*
TFP44
NOMESCO Finland
Ablation treatment of typical atrial flutter
+∞
6.3
6
*
I51.7
ICD-10 Finland
Cardiomegaly
+∞
6.3
6
*
AT7
HP
Replacing the pacemaker VVI (R) S
+∞
6.3
6
*
FPB22
NOMESCO Finland
Transvenous radiofrequency ablation of aberrant pathway or focus of heart
+∞
6.3
6
*
342
Kela drug reimbursment
Dronedarone
+∞
6.3
6
*
AQ2
HP
Electrophysiological electroanatomical examination
+∞
6.3
6
*
FPE10
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial electrode
+∞
6.3
6
*
4289X
ICD-9 Finland
Heart failure, unspecified
+∞
6.3
6
*
XF645
NOMESCO Finland
Heart ultrasound examination with load test
+∞
6.3
6
*
FXG00
NOMESCO Finland
Insertion and use of IABP
+∞
6.3
6
*
TFC20
NOMESCO Finland
Catheterisation of both sides of heart
+∞
6.3
6
*
FPE24
NOMESCO Finland
Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)
+∞
6.3
6
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
6.2
430
3590
T92
ICPC
Gout
3.6
6.2
20
57
C09AA01
ATC
captopril; oral
5.4
6.2
17
32
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.6
6.0
35
141
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
6.0
187
1323

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Cardiology
6 [38004451]
2.8e+00
3.8e+00
4.3e+00
1.0e+50
4.6e+00
4.5e+00
4.0e+00
cases:40.58%
controls:3.89%
cases:38.99%
controls:1.41%
cases:13.81%
controls:0.22%
cases:52.37%
controls:0.00%
cases:16.74%
controls:0.20%
cases:55.83%
controls:1.37%
cases:72.28%
controls:4.55%
282
270
413
6670
271
98
424
6842
96
15
599
6925
364
0
331
6940
113
14
562
6917
364
93
288
6717
425
280
163
5878
warfarin; oral, parenteral
B01AA03 [21600965]
3.0e+00
3.5e+00
2.9e+00
—
3.6e+00
3.3e+00
3.3e+00
cases:16.55%
controls:0.99%
cases:18.56%
controls:0.71%
cases:3.74%
controls:0.22%
—
—
cases:5.33%
controls:0.16%
cases:18.25%
controls:0.78%
cases:23.64%
controls:1.17%
115
69
580
6871
129
49
566
6891
26
15
669
6925
—
36
11
639
6920
119
53
533
6757
139
72
449
6086
spironolactone; oral
C03DA01 [21601534]
2.9e+00
3.3e+00
3.1e+00
—
3.5e+00
3.4e+00
2.9e+00
cases:11.80%
controls:0.72%
cases:13.38%
controls:0.55%
cases:3.31%
controls:0.16%
—
—
cases:4.15%
controls:0.13%
cases:13.50%
controls:0.53%
cases:16.50%
controls:1.04%
82
50
613
6890
93
38
602
6902
23
11
672
6929
—
28
9
647
6922
88
36
564
6774
97
64
491
6094
apixaban; oral
B01AF02 [43534762]
2.7e+00
3.1e+00
3.5e+00
—
3.6e+00
2.9e+00
2.8e+00
cases:3.17%
controls:0.22%
cases:4.46%
controls:0.22%
cases:2.73%
controls:0.09%
—
—
cases:2.52%
controls:0.07%
cases:4.91%
controls:0.28%
cases:6.80%
controls:0.42%
22
15
673
6925
31
15
664
6925
19
6
676
6934
—
17
5
658
6926
32
19
620
6791
40
26
548
6132
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 [3029187]
1.9e+00
2.6e+00
4.6e+00
—
3.3e+00
2.7e+00
2.4e+00
cases:11.37%
controls:1.93%
cases:10.50%
controls:0.88%
cases:7.77%
controls:0.09%
—
—
cases:4.74%
controls:0.19%
cases:13.50%
controls:1.00%
cases:29.08%
controls:3.62%
79
134
616
6806
73
61
622
6879
54
6
641
6934
—
32
13
643
6918
88
68
564
6742
171
223
417
5935
Ambulatory ECG
XF404 [2001303370]
3.8e+00
3.7e+00
—
1.0e+50
1.0e+50
4.2e+00
4.5e+00
cases:7.48%
controls:0.19%
cases:3.45%
controls:0.09%
—
—
cases:3.74%
controls:0.00%
cases:0.74%
controls:0.00%
cases:6.60%
controls:0.10%
cases:15.31%
controls:0.19%
52
13
643
6927
24
6
671
6934
—
26
0
669
6940
5
0
670
6931
43
7
609
6803
90
12
498
6146
furosemide; oral, parenteral
C03CA01 [21601518]
2.3e+00
2.6e+00
2.7e+00
—
3.0e+00
2.6e+00
2.4e+00
cases:19.28%
controls:2.35%
cases:21.15%
controls:1.97%
cases:7.48%
controls:0.55%
—
—
cases:9.48%
controls:0.52%
cases:23.62%
controls:2.19%
cases:31.12%
controls:3.78%
134
163
561
6777
147
137
548
6803
52
38
643
6902
—
64
36
611
6895
154
149
498
6661
183
233
405
5925
bisoprolol; oral
C07AB07 [21601689]
1.6e+00
1.9e+00
1.9e+00
3.1e+00
2.3e+00
2.3e+00
2.3e+00
cases:31.94%
controls:8.76%
cases:36.40%
controls:7.81%
cases:12.95%
controls:2.13%
cases:2.59%
controls:0.12%
cases:19.26%
controls:2.31%
cases:48.31%
controls:8.33%
cases:56.63%
controls:11.33%
222
608
473
6332
253
542
442
6398
90
148
605
6792
18
8
677
6932
130
160
545
6771
315
567
337
6243
333
698
255
5460
Standard cardiac ultrasound examination
FM1AE [2001303278]
3.1e+00
3.7e+00
—
1.0e+50
—
4.5e+00
4.1e+00
cases:17.99%
controls:0.97%
cases:13.09%
controls:0.39%
—
—
cases:15.40%
controls:0.00%
—
—
cases:20.55%
controls:0.28%
cases:37.07%
controls:0.96%
125
67
570
6873
91
27
604
6913
—
107
0
588
6940
—
134
19
518
6791
218
59
370
6099
digoxin; oral, parenteral
C01AA05 [21600234]
3.5e+00
3.5e+00
—
—
—
4.1e+00
4.1e+00
cases:6.76%
controls:0.22%
cases:7.05%
controls:0.23%
—
—
—
—
—
—
cases:7.98%
controls:0.15%
cases:9.35%
controls:0.18%
47
15
648
6925
49
16
646
6924
—
—
—
52
10
600
6800
55
11
533
6147
Medical doctor
Z2221 [2001311556]
1.4e+00
2.5e+00
3.1e+00
—
2.9e+00
2.6e+00
2.2e+00
cases:12.95%
controls:3.62%
cases:9.78%
controls:0.86%
cases:2.73%
controls:0.13%
—
—
cases:2.67%
controls:0.14%
cases:12.73%
controls:1.09%
cases:20.41%
controls:2.87%
90
251
605
6689
68
60
627
6880
19
9
676
6931
—
18
10
657
6921
83
74
569
6736
120
177
468
5981
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
2.4e+00
3.5e+00
—
1.0e+50
—
3.6e+00
3.5e+00
cases:12.23%
controls:1.24%
cases:10.36%
controls:0.33%
—
—
cases:11.51%
controls:0.00%
—
—
cases:13.96%
controls:0.43%
cases:29.76%
controls:1.23%
85
86
610
6854
72
23
623
6917
—
80
0
615
6940
—
91
29
561
6781
175
76
413
6082
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
1.3e+00
1.7e+00
3.2e+00
1.0e+50
3.0e+00
2.1e+00
1.5e+00
cases:5.47%
controls:1.53%
cases:4.46%
controls:0.88%
cases:2.45%
controls:0.10%
cases:2.01%
controls:0.00%
cases:2.96%
controls:0.14%
cases:5.83%
controls:0.76%
cases:10.20%
controls:2.37%
38
106
657
6834
31
61
664
6879
17
7
678
6933
14
0
681
6940
20
10
655
6921
38
52
614
6758
60
146
528
6012
Outpatient Visit
OP [9202]
7.3e-01
1.0e+00
1.1e+00
5.6e+00
1.3e+00
1.5e+00
1.5e+00
cases:73.96%
controls:57.69%
cases:63.17%
controls:38.72%
cases:22.88%
controls:8.70%
cases:53.53%
controls:0.42%
cases:24.74%
controls:8.22%
cases:74.85%
controls:39.82%
cases:91.67%
controls:70.09%
514
4004
181
2936
439
2687
256
4253
159
604
536
6336
372
29
323
6911
167
570
508
6361
488
2712
164
4098
539
4316
49
1842
Atherosclerotic heart disease
I25.1 [45596196]
1.4e+00
2.0e+00
2.4e+00
—
2.9e+00
2.3e+00
1.8e+00
cases:8.63%
controls:2.28%
cases:7.63%
controls:1.11%
cases:2.30%
controls:0.22%
—
—
cases:3.11%
controls:0.17%
cases:11.35%
controls:1.22%
cases:17.01%
controls:3.35%
60
158
635
6782
53
77
642
6863
16
15
679
6925
—
21
12
654
6919
74
83
578
6727
100
206
488
5952
Thorax X-ray examination
GD1AA [2001303617]
1.4e+00
2.1e+00
3.2e+00
—
2.2e+00
1.9e+00
1.7e+00
cases:17.41%
controls:4.73%
cases:12.66%
controls:1.74%
cases:2.88%
controls:0.12%
—
—
cases:2.81%
controls:0.32%
cases:10.89%
controls:1.73%
cases:25.68%
controls:5.68%
121
328
574
6612
88
121
607
6819
20
8
675
6932
—
19
22
656
6909
71
118
581
6692
151
350
437
5808
Internal Medicine
11 [38004456]
1.4e+00
1.8e+00
2.7e+00
1.0e+50
2.6e+00
2.1e+00
1.9e+00
cases:42.73%
controls:15.86%
cases:30.36%
controls:6.71%
cases:9.78%
controls:0.73%
cases:36.55%
controls:0.00%
cases:12.30%
controls:1.04%
cases:35.28%
controls:6.18%
cases:55.61%
controls:16.09%
297
1101
398
5839
211
466
484
6474
68
51
627
6889
254
0
441
6940
83
72
592
6859
230
421
422
6389
327
991
261
5167
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
1.0e+00
1.6e+00
3.4e+00
—
3.0e+00
1.6e+00
1.2e+00
cases:8.78%
controls:3.30%
cases:7.91%
controls:1.70%
cases:3.45%
controls:0.12%
—
—
cases:3.70%
controls:0.19%
cases:7.67%
controls:1.62%
cases:15.99%
controls:5.60%
61
229
634
6711
55
118
640
6822
24
8
671
6932
—
25
13
650
6918
50
110
602
6700
94
345
494
5813
potassium chloride; oral
A12BA01 [21600877]
1.4e+00
1.8e+00
2.2e+00
—
2.6e+00
1.8e+00
1.9e+00
cases:4.17%
controls:1.05%
cases:3.74%
controls:0.62%
cases:1.58%
controls:0.17%
—
—
cases:1.93%
controls:0.14%
cases:3.68%
controls:0.63%
cases:7.82%
controls:1.22%
29
73
666
6867
26
43
669
6897
11
12
684
6928
—
13
10
662
6921
24
43
628
6767
46
75
542
6083
INR in Blood by Coagulation assay
34714-6 [3032080]
9.5e-01
1.4e+00
3.1e+00
—
2.5e+00
1.8e+00
1.5e+00
cases:10.94%
controls:4.52%
cases:9.93%
controls:2.58%
cases:6.33%
controls:0.30%
—
—
cases:6.37%
controls:0.58%
cases:11.35%
controls:2.07%
cases:23.30%
controls:6.09%
76
314
619
6626
69
179
626
6761
44
21
651
6919
—
43
40
632
6891
74
141
578
6669
137
375
451
5783
Electrocardiogram with exercise test
46136006 [4261794]
2.3e+00
2.6e+00
—
1.0e+50
—
3.3e+00
2.7e+00
cases:6.76%
controls:0.73%
cases:2.73%
controls:0.22%
—
—
cases:2.88%
controls:0.00%
—
—
cases:4.75%
controls:0.18%
cases:9.69%
controls:0.73%
47
51
648
6889
19
15
676
6925
—
20
0
675
6940
—
31
12
621
6798
57
45
531
6113
Extensive angiography of hear and/or coronary arteries
FN1BC [2001303000]
2.3e+00
3.3e+00
—
1.0e+50
—
2.4e+00
2.8e+00
cases:3.17%
controls:0.32%
cases:2.01%
controls:0.07%
—
—
cases:0.72%
controls:0.00%
—
—
cases:0.77%
controls:0.07%
cases:3.23%
controls:0.21%
22
22
673
6918
14
5
681
6935
—
5
0
690
6940
—
5
5
647
6805
19
13
569
6145
mycophenolic acid; oral, parenteral
L04AA06 [21603896]
1.9e+00
2.2e+00
—
—
—
3.1e+00
3.5e+00
cases:1.15%
controls:0.17%
cases:1.15%
controls:0.13%
—
—
—
—
—
—
cases:2.45%
controls:0.12%
cases:3.57%
controls:0.11%
8
12
687
6928
8
9
687
6931
—
—
—
16
8
636
6802
21
7
567
6151
perindopril; oral
C09AA04 [21601788]
1.6e+00
1.9e+00
2.0e+00
—
1.8e+00
1.9e+00
1.5e+00
cases:3.60%
controls:0.78%
cases:3.88%
controls:0.59%
cases:1.44%
controls:0.20%
—
—
cases:1.19%
controls:0.20%
cases:3.68%
controls:0.59%
cases:3.74%
controls:0.89%
25
54
670
6886
27
41
668
6899
10
14
685
6926
—
8
14
667
6917
24
40
628
6770
22
55
566
6103
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
2.2e+00
2.4e+00
—
—
—
2.9e+00
2.6e+00
cases:4.17%
controls:0.48%
cases:3.17%
controls:0.29%
—
—
—
—
—
—
cases:4.60%
controls:0.26%
cases:7.99%
controls:0.65%
29
33
666
6907
22
20
673
6920
—
—
—
30
18
622
6792
47
40
541
6118
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
1.2e+00
2.2e+00
—
—
3.4e+00
1.7e+00
1.4e+00
cases:3.60%
controls:1.17%
cases:4.46%
controls:0.49%
—
—
—
—
cases:2.22%
controls:0.07%
cases:3.99%
controls:0.75%
cases:8.50%
controls:2.31%
25
81
670
6859
31
34
664
6906
—
—
15
5
660
6926
26
51
626
6759
50
142
538
6016
Dyspnoea
R06.0 [45558449]
1.4e+00
2.2e+00
—
1.0e+50
3.1e+00
1.8e+00
1.3e+00
cases:6.62%
controls:1.80%
cases:6.19%
controls:0.73%
—
—
cases:1.15%
controls:0.00%
cases:1.63%
controls:0.07%
cases:3.37%
controls:0.57%
cases:9.01%
controls:2.53%
46
125
649
6815
43
51
652
6889
—
8
0
687
6940
11
5
664
6926
22
39
630
6771
53
156
535
6002
Physiotherapy
R4110 [2001310233]
8.6e-01
1.3e+00
2.4e+00
—
2.3e+00
1.5e+00
1.3e+00
cases:7.34%
controls:3.23%
cases:4.75%
controls:1.31%
cases:1.15%
controls:0.10%
—
—
cases:1.48%
controls:0.14%
cases:5.21%
controls:1.23%
cases:10.71%
controls:3.25%
51
224
644
6716
33
91
662
6849
8
7
687
6933
—
10
10
665
6921
34
84
618
6726
63
200
525
5958
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
7.4e-01
1.6e+00
1.9e+00
—
3.0e+00
1.5e+00
1.0e+00
cases:4.46%
controls:2.18%
cases:4.60%
controls:0.95%
cases:1.01%
controls:0.16%
—
—
cases:1.63%
controls:0.09%
cases:4.29%
controls:0.95%
cases:8.67%
controls:3.35%
31
151
664
6789
32
66
663
6874
7
11
688
6929
—
11
6
664
6925
28
65
624
6745
51
206
537
5952
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
1.1e+00
2.3e+00
—
—
3.1e+00
1.7e+00
1.4e+00
cases:2.73%
controls:0.94%
cases:4.46%
controls:0.46%
—
—
—
—
cases:1.93%
controls:0.09%
cases:3.22%
controls:0.59%
cases:7.82%
controls:1.98%
19
65
676
6875
31
32
664
6908
—
—
13
6
662
6925
21
40
631
6770
46
122
542
6036
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2.4e-01
5.2e-01
1.9e+00
4.4e+00
1.7e+00
5.9e-01
4.2e-01
cases:22.45%
controls:18.49%
cases:21.58%
controls:14.09%
cases:15.25%
controls:2.59%
cases:6.76%
controls:0.09%
cases:12.00%
controls:2.44%
cases:24.39%
controls:15.21%
cases:42.35%
controls:32.51%
156
1283
539
5657
150
978
545
5962
106
180
589
6760
47
6
648
6934
81
169
594
6762
159
1036
493
5774
249
2002
339
4156
sotalol; oral, parenteral
C07AA07 [21601672]
2.9e+00
2.9e+00
—
—
—
—
3.7e+00
cases:1.87%
controls:0.10%
cases:1.29%
controls:0.07%
—
—
—
—
—
—
—
—
cases:3.74%
controls:0.10%
13
7
682
6933
9
5
686
6935
—
—
—
—
22
6
566
6152
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2.4e-01
5.2e-01
1.9e+00
4.4e+00
1.7e+00
5.8e-01
4.0e-01
cases:22.59%
controls:18.69%
cases:21.87%
controls:14.28%
cases:15.54%
controls:2.65%
cases:6.62%
controls:0.09%
cases:11.85%
controls:2.51%
cases:24.54%
controls:15.42%
cases:42.35%
controls:32.98%
157
1297
538
5643
152
991
543
5949
108
184
587
6756
46
6
649
6934
80
174
595
6757
160
1050
492
5760
249
2031
339
4127
ramipril; oral
C09AA05 [21601789]
1.5e+00
1.7e+00
1.7e+00
—
1.8e+00
1.5e+00
1.2e+00
cases:16.83%
controls:4.41%
cases:16.98%
controls:3.67%
cases:5.90%
controls:1.15%
—
—
cases:6.37%
controls:1.07%
cases:15.80%
controls:3.96%
cases:17.86%
controls:5.89%
117
306
578
6634
118
255
577
6685
41
80
654
6860
—
43
74
632
6857
103
270
549
6540
105
363
483
5795
Angiography of the heart and coronary arteries
81 [2002100125]
2.2e+00
2.6e+00
—
—
—
2.4e+00
2.2e+00
cases:2.59%
controls:0.29%
cases:1.01%
controls:0.07%
—
—
—
—
—
—
cases:0.92%
controls:0.09%
cases:2.04%
controls:0.23%
18
20
677
6920
7
5
688
6935
—
—
—
6
6
646
6804
12
14
576
6144
Angiography of heart and/or coronary arteries
FN1AC [2001302996]
1.9e+00
2.5e+00
—
1.0e+50
—
2.6e+00
2.3e+00
cases:11.94%
controls:1.93%
cases:5.76%
controls:0.50%
—
—
cases:4.75%
controls:0.00%
—
—
cases:5.98%
controls:0.47%
cases:15.31%
controls:1.75%
83
134
612
6806
40
35
655
6905
—
33
0
662
6940
—
39
32
613
6778
90
108
498
6050
Doppler ultrasound examination of heart
FM1DE [2001303299]
2.9e+00
3.3e+00
—
1.0e+50
—
—
3.2e+00
cases:6.04%
controls:0.36%
cases:3.60%
controls:0.14%
—
—
cases:3.45%
controls:0.00%
—
—
—
—
cases:8.84%
controls:0.41%
42
25
653
6915
25
10
670
6930
—
24
0
671
6940
—
—
52
25
536
6133
Chest pain, unspecified
R07.4 [45558450]
1.3e+00
1.8e+00
3.0e+00
1.0e+50
1.9e+00
1.8e+00
1.2e+00
cases:8.35%
controls:2.35%
cases:4.89%
controls:0.84%
cases:2.01%
controls:0.10%
cases:0.72%
controls:0.00%
cases:0.74%
controls:0.12%
cases:4.60%
controls:0.78%
cases:10.20%
controls:3.26%
58
163
637
6777
34
58
661
6882
14
7
681
6933
5
0
690
6940
5
8
670
6923
30
53
622
6757
60
201
528
5957
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
1.3e+00
2.0e+00
—
1.0e+50
—
3.2e+00
2.7e+00
cases:2.73%
controls:0.73%
cases:2.88%
controls:0.42%
—
—
cases:1.73%
controls:0.00%
—
—
cases:5.67%
controls:0.25%
cases:7.48%
controls:0.55%
19
51
676
6889
20
29
675
6911
—
12
0
683
6940
—
37
17
615
6793
44
34
544
6124
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
9.7e-01
2.1e+00
—
—
3.0e+00
1.7e+00
1.4e+00
cases:2.59%
controls:0.99%
cases:4.17%
controls:0.52%
—
—
—
—
cases:1.93%
controls:0.10%
cases:3.37%
controls:0.66%
cases:8.16%
controls:2.21%
18
69
677
6871
29
36
666
6904
—
—
13
7
662
6924
22
45
630
6765
48
136
540
6022
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
1.3e+00
1.2e+00
—
—
2.8e+00
1.9e+00
1.7e+00
cases:2.30%
controls:0.63%
cases:2.01%
controls:0.59%
—
—
—
—
cases:1.63%
controls:0.10%
cases:3.07%
controls:0.46%
cases:5.27%
controls:0.99%
16
44
679
6896
14
41
681
6899
—
—
11
7
664
6924
20
31
632
6779
31
61
557
6097
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
9.1e-01
1.3e+00
—
—
3.4e+00
1.8e+00
1.5e+00
cases:3.17%
controls:1.30%
cases:3.02%
controls:0.81%
—
—
—
—
cases:2.52%
controls:0.09%
cases:3.07%
controls:0.50%
cases:6.80%
controls:1.61%
22
90
673
6850
21
56
674
6884
—
—
17
6
658
6925
20
34
632
6776
40
99
548
6059
CBC panel - Blood by Automated count
58410-2 [40761511]
2.2e-01
5.0e-01
1.8e+00
4.2e+00
1.6e+00
5.0e-01
3.6e-01
cases:21.15%
controls:17.78%
cases:18.13%
controls:11.87%
cases:9.93%
controls:1.74%
cases:4.46%
controls:0.07%
cases:8.74%
controls:1.85%
cases:18.10%
controls:11.81%
cases:37.41%
controls:29.43%
147
1234
548
5706
126
824
569
6116
69
121
626
6819
31
5
664
6935
59
128
616
6803
118
804
534
6006
220
1812
368
4346
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
7.5e-01
1.5e+00
2.2e+00
—
2.5e+00
1.2e+00
8.6e-01
cases:7.05%
controls:3.44%
cases:7.19%
controls:1.73%
cases:1.73%
controls:0.20%
—
—
cases:2.81%
controls:0.25%
cases:6.44%
controls:1.97%
cases:13.78%
controls:6.32%
49
239
646
6701
50
120
645
6820
12
14
683
6926
—
19
17
656
6914
42
134
610
6676
81
389
507
5769
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
1.7e-01
4.7e-01
1.8e+00
4.3e+00
1.5e+00
5.0e-01
3.0e-01
cases:23.02%
controls:20.17%
cases:23.88%
controls:16.38%
cases:17.27%
controls:3.23%
cases:6.76%
controls:0.10%
cases:12.44%
controls:3.15%
cases:26.07%
controls:17.67%
cases:42.86%
controls:35.64%
160
1400
535
5540
166
1137
529
5803
120
224
575
6716
47
7
648
6933
84
218
591
6713
170
1203
482
5607
252
2195
336
3963
Coronary angiography
AN1 [2000200163]
1.7e+00
2.6e+00
—
1.0e+50
—
2.6e+00
2.0e+00
cases:5.61%
controls:1.11%
cases:3.31%
controls:0.26%
—
—
cases:1.44%
controls:0.00%
—
—
cases:2.45%
controls:0.19%
cases:5.44%
controls:0.80%
39
77
656
6863
23
18
672
6922
—
10
0
685
6940
—
16
13
636
6797
32
49
556
6109
Outpatient Hospital
22 [8756]
7.4e-01
1.4e+00
1.8e+00
1.0e+50
2.2e+00
1.4e+00
1.2e+00
cases:33.67%
controls:19.57%
cases:20.00%
controls:6.05%
cases:4.32%
controls:0.76%
cases:10.65%
controls:0.00%
cases:5.63%
controls:0.63%
cases:20.40%
controls:6.18%
cases:41.16%
controls:17.39%
234
1358
461
5582
139
420
556
6520
30
53
665
6887
74
0
621
6940
38
44
637
6887
133
421
519
6389
242
1071
346
5087
Emergency Room Visit
ER [9203]
8.0e-01
1.5e+00
2.0e+00
1.0e+50
2.1e+00
1.2e+00
1.0e+00
cases:41.29%
controls:23.96%
cases:28.78%
controls:8.41%
cases:7.34%
controls:1.04%
cases:13.96%
controls:0.00%
cases:7.11%
controls:0.94%
cases:23.62%
controls:8.68%
cases:49.66%
controls:25.71%
287
1663
408
5277
200
584
495
6356
51
72
644
6868
97
0
598
6940
48
65
627
6866
154
591
498
6219
292
1583
296
4575
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
6.4e-01
8.3e-01
2.3e+00
—
2.5e+00
1.4e+00
8.4e-01
cases:5.32%
controls:2.88%
cases:3.31%
controls:1.47%
cases:1.01%
controls:0.10%
—
—
cases:1.78%
controls:0.14%
cases:4.29%
controls:1.07%
cases:9.35%
controls:4.27%
37
200
658
6740
23
102
672
6838
7
7
688
6933
—
12
10
663
6921
28
73
624
6737
55
263
533
5895
ECG with 12 standard connections
XF400 [2001303368]
1.5e+00
2.0e+00
1.0e+50
1.0e+50
—
2.8e+00
2.3e+00
cases:5.61%
controls:1.33%
cases:3.31%
controls:0.46%
cases:0.86%
controls:0.00%
cases:2.16%
controls:0.00%
—
—
cases:3.68%
controls:0.23%
cases:7.99%
controls:0.89%
39
92
656
6848
23
32
672
6908
6
0
689
6940
15
0
680
6940
—
24
16
628
6794
47
55
541
6103
Inpatient Hospital
21 [8717]
7.3e-01
1.3e+00
1.8e+00
—
2.2e+00
1.2e+00
1.1e+00
cases:41.15%
controls:25.17%
cases:26.62%
controls:8.67%
cases:6.91%
controls:1.24%
—
—
cases:8.15%
controls:0.97%
cases:24.69%
controls:8.91%
cases:47.28%
controls:22.95%
286
1747
409
5193
185
602
510
6338
48
86
647
6854
—
55
67
620
6864
161
607
491
6203
278
1413
310
4745
Office Visit
OMOP4822458 [581477]
8.1e-01
1.2e+00
1.9e+00
—
2.0e+00
1.3e+00
1.1e+00
cases:13.09%
controls:6.25%
cases:6.62%
controls:2.02%
cases:2.16%
controls:0.32%
—
—
cases:2.52%
controls:0.33%
cases:7.52%
controls:2.23%
cases:15.99%
controls:6.19%
91
434
604
6506
46
140
649
6800
15
22
680
6918
—
17
23
658
6908
49
152
603
6658
94
381
494
5777
12 lead EKG panel
34534-8 [3044889]
5.9e-01
1.2e+00
2.3e+00
—
2.1e+00
1.2e+00
9.3e-01
cases:15.97%
controls:9.55%
cases:14.68%
controls:4.84%
cases:6.33%
controls:0.66%
—
—
cases:4.30%
controls:0.55%
cases:15.18%
controls:5.15%
cases:32.31%
controls:15.80%
111
663
584
6277
102
336
593
6604
44
46
651
6894
—
29
38
646
6893
99
351
553
6459
190
973
398
5185
Observation for other suspected cardiovascular diseases
Z03.5 [45590692]
1.8e+00
2.3e+00
1.0e+50
—
—
2.4e+00
1.8e+00
cases:3.17%
controls:0.52%
cases:1.44%
controls:0.14%
cases:0.72%
controls:0.00%
—
—
—
—
cases:1.38%
controls:0.13%
cases:2.89%
controls:0.49%
22
36
673
6904
10
10
685
6930
5
0
690
6940
—
—
9
9
643
6801
17
30
571
6128
verapamil; oral, parenteral
C08DA01 [21601767]
1.8e+00
1.7e+00
—
—
—
2.1e+00
2.7e+00
cases:1.73%
controls:0.30%
cases:1.15%
controls:0.22%
—
—
—
—
—
—
cases:1.53%
controls:0.19%
cases:3.91%
controls:0.26%
12
21
683
6919
8
15
687
6925
—
—
—
10
13
642
6797
23
16
565
6142
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
1.2e-01
3.8e-01
1.6e+00
4.4e+00
1.4e+00
3.9e-01
2.4e-01
cases:23.45%
controls:21.34%
cases:24.03%
controls:17.72%
cases:15.83%
controls:3.65%
cases:6.76%
controls:0.09%
cases:13.19%
controls:3.46%
cases:25.31%
controls:18.72%
cases:43.71%
controls:37.85%
163
1481
532
5459
167
1230
528
5710
110
253
585
6687
47
6
648
6934
89
240
586
6691
165
1275
487
5535
257
2331
331
3827
MCH [Entitic mass]
28539-5 [3035941]
1.3e-01
3.9e-01
1.6e+00
4.4e+00
1.4e+00
3.9e-01
2.5e-01
cases:23.45%
controls:21.27%
cases:24.03%
controls:17.64%
cases:15.83%
controls:3.63%
cases:6.62%
controls:0.09%
cases:13.19%
controls:3.46%
cases:25.15%
controls:18.60%
cases:43.71%
controls:37.66%
163
1476
532
5464
167
1224
528
5716
110
252
585
6688
46
6
649
6934
89
240
586
6691
164
1267
488
5543
257
2319
331
3839
Platelets [#/volume] in Blood
26515-7 [3007461]
1.2e-01
3.9e-01
1.6e+00
4.4e+00
1.4e+00
3.8e-01
2.5e-01
cases:23.31%
controls:21.21%
cases:24.03%
controls:17.62%
cases:15.83%
controls:3.63%
cases:6.62%
controls:0.09%
cases:13.19%
controls:3.46%
cases:25.15%
controls:18.65%
cases:43.71%
controls:37.64%
162
1472
533
5468
167
1223
528
5717
110
252
585
6688
46
6
649
6934
89
240
586
6691
164
1270
488
5540
257
2318
331
3840
Leukocytes [#/volume] in Blood
26464-8 [3010813]
1.2e-01
3.9e-01
1.6e+00
4.4e+00
1.4e+00
3.9e-01
2.5e-01
cases:23.45%
controls:21.31%
cases:24.17%
controls:17.72%
cases:15.83%
controls:3.63%
cases:6.62%
controls:0.09%
cases:13.19%
controls:3.49%
cases:25.31%
controls:18.69%
cases:43.71%
controls:37.76%
163
1479
532
5461
168
1230
527
5710
110
252
585
6688
46
6
649
6934
89
242
586
6689
165
1273
487
5537
257
2325
331
3833
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
1.2e-01
3.9e-01
1.6e+00
4.4e+00
1.4e+00
3.9e-01
2.5e-01
cases:23.45%
controls:21.33%
cases:24.03%
controls:17.71%
cases:15.83%
controls:3.63%
cases:6.62%
controls:0.09%
cases:13.19%
controls:3.46%
cases:25.31%
controls:18.72%
cases:43.71%
controls:37.72%
163
1480
532
5460
167
1229
528
5711
110
252
585
6688
46
6
649
6934
89
240
586
6691
165
1275
487
5535
257
2323
331
3835
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
1.2e-01
3.9e-01
1.6e+00
4.4e+00
1.4e+00
3.9e-01
2.5e-01
cases:23.45%
controls:21.31%
cases:24.03%
controls:17.68%
cases:15.83%
controls:3.65%
cases:6.62%
controls:0.09%
cases:13.19%
controls:3.46%
cases:25.31%
controls:18.71%
cases:43.71%
controls:37.72%
163
1479
532
5461
167
1227
528
5713
110
253
585
6687
46
6
649
6934
89
240
586
6691
165
1274
487
5536
257
2323
331
3835
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
1.2e-01
3.9e-01
1.6e+00
4.4e+00
1.4e+00
3.8e-01
2.5e-01
cases:23.45%
controls:21.33%
cases:24.03%
controls:17.69%
cases:15.83%
controls:3.63%
cases:6.62%
controls:0.09%
cases:13.19%
controls:3.46%
cases:25.15%
controls:18.63%
cases:43.71%
controls:37.74%
163
1480
532
5460
167
1228
528
5712
110
252
585
6688
46
6
649
6934
89
240
586
6691
164
1269
488
5541
257
2324
331
3834
Physiotherapist
Z3226 [2001311560]
7.6e-01
2.0e+00
—
1.0e+50
2.5e+00
1.5e+00
1.4e+00
cases:4.32%
controls:2.06%
cases:3.17%
controls:0.46%
—
—
cases:1.15%
controls:0.00%
cases:0.89%
controls:0.07%
cases:2.76%
controls:0.60%
cases:6.29%
controls:1.67%
30
143
665
6797
22
32
673
6908
—
8
0
687
6940
6
5
669
6926
18
41
634
6769
37
103
551
6055
tacrolimus; oral, parenteral
L04AD02 [21603925]
2.5e+00
2.5e+00
—
—
—
3.1e+00
—
cases:0.86%
controls:0.07%
cases:0.86%
controls:0.07%
—
—
—
—
—
—
cases:1.69%
controls:0.07%
—
—
6
5
689
6935
6
5
689
6935
—
—
—
11
5
641
6805
—
FEV1
20150-9 [3024653]
1.6e+00
1.8e+00
—
—
—
2.4e+00
2.3e+00
cases:4.03%
controls:0.85%
cases:2.30%
controls:0.37%
—
—
—
—
—
—
cases:2.15%
controls:0.21%
cases:4.76%
controls:0.49%
28
59
667
6881
16
26
679
6914
—
—
—
14
14
638
6796
28
30
560
6128
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
1.6e+00
1.8e+00
—
—
—
2.4e+00
2.3e+00
cases:4.03%
controls:0.85%
cases:2.30%
controls:0.37%
—
—
—
—
—
—
cases:2.15%
controls:0.21%
cases:4.76%
controls:0.49%
28
59
667
6881
16
26
679
6914
—
—
—
14
14
638
6796
28
30
560
6128
FEV1/FVC
19926-5 [3011505]
1.6e+00
1.8e+00
—
—
—
2.4e+00
2.3e+00
cases:4.03%
controls:0.85%
cases:2.30%
controls:0.37%
—
—
—
—
—
—
cases:2.15%
controls:0.21%
cases:4.76%
controls:0.49%
28
59
667
6881
16
26
679
6914
—
—
—
14
14
638
6796
28
30
560
6128
One hour or less
ZXE00 [2001311394]
1.0e+00
1.5e+00
1.8e+00
1.0e+50
2.2e+00
1.8e+00
1.6e+00
cases:10.94%
controls:4.32%
cases:6.04%
controls:1.48%
cases:0.72%
controls:0.12%
cases:2.16%
controls:0.00%
cases:1.04%
controls:0.12%
cases:6.29%
controls:1.06%
cases:16.16%
controls:3.82%
76
300
619
6640
42
103
653
6837
5
8
690
6932
15
0
680
6940
7
8
668
6923
41
72
611
6738
95
235
493
5923
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
8.4e-01
9.8e-01
2.1e+00
—
2.4e+00
1.2e+00
1.3e+00
cases:2.73%
controls:1.20%
cases:2.30%
controls:0.88%
cases:1.01%
controls:0.13%
—
—
cases:1.78%
controls:0.16%
cases:2.45%
controls:0.72%
cases:5.44%
controls:1.61%
19
83
676
6857
16
61
679
6879
7
9
688
6931
—
12
11
663
6920
16
49
636
6761
32
99
556
6059
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
1.7e+00
2.2e+00
—
1.0e+50
—
2.0e+00
2.0e+00
cases:3.17%
controls:0.58%
cases:2.30%
controls:0.26%
—
—
cases:0.72%
controls:0.00%
—
—
cases:2.91%
controls:0.41%
cases:5.95%
controls:0.83%
22
40
673
6900
16
18
679
6922
—
5
0
690
6940
—
19
28
633
6782
35
51
553
6107
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 [3034780]
1.7e+00
2.6e+00
—
—
—
2.2e+00
1.4e+00
cases:1.44%
controls:0.26%
cases:1.73%
controls:0.13%
—
—
—
—
—
—
cases:1.07%
controls:0.12%
cases:2.04%
controls:0.54%
10
18
685
6922
12
9
683
6931
—
—
—
7
8
645
6802
12
33
576
6125
FVC percent change Respiratory system
69982-7 [42868471]
1.6e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:3.74%
controls:0.75%
cases:2.16%
controls:0.35%
—
—
—
—
—
—
cases:1.84%
controls:0.19%
cases:3.74%
controls:0.47%
26
52
669
6888
15
24
680
6916
—
—
—
12
13
640
6797
22
29
566
6129
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
1.6e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:3.74%
controls:0.75%
cases:2.16%
controls:0.35%
—
—
—
—
—
—
cases:1.84%
controls:0.19%
cases:3.74%
controls:0.47%
26
52
669
6888
15
24
680
6916
—
—
—
12
13
640
6797
22
29
566
6129
FEV1/FVC --post bronchodilation
69970-2 [42868459]
1.6e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:3.74%
controls:0.75%
cases:2.16%
controls:0.35%
—
—
—
—
—
—
cases:1.84%
controls:0.19%
cases:3.74%
controls:0.47%
26
52
669
6888
15
24
680
6916
—
—
—
12
13
640
6797
22
29
566
6129
FEV1 --post bronchodilation
20155-8 [3023550]
1.6e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:3.74%
controls:0.75%
cases:2.16%
controls:0.35%
—
—
—
—
—
—
cases:1.84%
controls:0.19%
cases:3.74%
controls:0.47%
26
52
669
6888
15
24
680
6916
—
—
—
12
13
640
6797
22
29
566
6129
FEV1 percent change
69983-5 [42868472]
1.6e+00
1.8e+00
—
—
—
2.3e+00
2.1e+00
cases:3.74%
controls:0.75%
cases:2.16%
controls:0.35%
—
—
—
—
—
—
cases:1.84%
controls:0.19%
cases:3.74%
controls:0.47%
26
52
669
6888
15
24
680
6916
—
—
—
12
13
640
6797
22
29
566
6129
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
1.4e+00
2.0e+00
—
1.0e+50
—
2.5e+00
1.9e+00
cases:4.32%
controls:1.11%
cases:3.17%
controls:0.46%
—
—
cases:2.16%
controls:0.00%
—
—
cases:4.14%
controls:0.35%
cases:6.46%
controls:1.06%
30
77
665
6863
22
32
673
6908
—
15
0
680
6940
—
27
24
625
6786
38
65
550
6093
Syncope and collapse
R55 [45568141]
1.4e+00
2.2e+00
—
1.0e+50
—
2.4e+00
1.7e+00
cases:2.88%
controls:0.73%
cases:1.87%
controls:0.22%
—
—
cases:1.29%
controls:0.00%
—
—
cases:2.15%
controls:0.21%
cases:4.76%
controls:0.91%
20
51
675
6889
13
15
682
6925
—
9
0
686
6940
—
14
14
638
6796
28
56
560
6102
metoprolol; oral, parenteral
C07AB02 [21601684]
1.1e+00
1.2e+00
1.0e+00
—
1.4e+00
1.4e+00
1.4e+00
cases:11.94%
controls:4.47%
cases:11.22%
controls:3.59%
cases:3.02%
controls:1.11%
—
—
cases:4.00%
controls:1.01%
cases:13.34%
controls:3.55%
cases:16.16%
controls:4.63%
83
310
612
6630
78
249
617
6691
21
77
674
6863
—
27
70
648
6861
87
242
565
6568
95
285
493
5873
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
4.6e-01
9.6e-01
2.2e+00
1.0e+50
2.0e+00
1.1e+00
8.0e-01
cases:10.50%
controls:6.87%
cases:8.92%
controls:3.63%
cases:3.17%
controls:0.36%
cases:2.88%
controls:0.00%
cases:3.26%
controls:0.48%
cases:8.90%
controls:3.05%
cases:18.88%
controls:9.50%
73
477
622
6463
62
252
633
6688
22
25
673
6915
20
0
675
6940
22
33
653
6898
58
208
594
6602
111
585
477
5573
EKG study
11524-6 [3013512]
2.9e-01
7.3e-01
3.1e+00
—
1.6e+00
1.3e+00
6.2e-01
cases:5.18%
controls:3.92%
cases:4.46%
controls:2.20%
cases:4.46%
controls:0.20%
—
—
cases:1.48%
controls:0.29%
cases:6.44%
controls:1.92%
cases:11.39%
controls:6.48%
36
272
659
6668
31
153
664
6787
31
14
664
6926
—
10
20
665
6911
42
131
610
6679
67
399
521
5759
Pulmonary Disease
29 [38004472]
9.2e-01
1.2e+00
1.5e+00
—
1.6e+00
1.0e+00
1.1e+00
cases:14.39%
controls:6.30%
cases:10.50%
controls:3.47%
cases:3.31%
controls:0.76%
—
—
cases:3.11%
controls:0.66%
cases:8.74%
controls:3.29%
cases:18.54%
controls:7.11%
100
437
595
6503
73
241
622
6699
23
53
672
6887
—
21
46
654
6885
57
224
595
6586
109
438
479
5720
isosorbide dinitrate; local oral, oral, sublingual, transdermal
C01DA08 [21600321]
1.0e+00
1.2e+00
1.3e+00
—
2.6e+00
1.2e+00
1.0e+00
cases:8.20%
controls:3.17%
cases:5.61%
controls:1.69%
cases:1.01%
controls:0.29%
—
—
cases:3.11%
controls:0.23%
cases:5.83%
controls:1.78%
cases:11.39%
controls:4.37%
57
220
638
6720
39
117
656
6823
7
20
688
6920
—
21
16
654
6915
38
121
614
6689
67
269
521
5889
Cardiac arrhythmia, unspecified
I49.9 [45581778]
2.4e+00
—
—
—
—
2.7e+00
2.0e+00
cases:2.88%
controls:0.27%
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.10%
cases:3.57%
controls:0.49%
20
19
675
6921
—
—
—
—
10
7
642
6803
21
30
567
6128
Intensive care
WX872 [2001310844]
1.2e+00
2.3e+00
—
—
—
2.9e+00
1.9e+00
cases:0.86%
controls:0.27%
cases:1.01%
controls:0.10%
—
—
—
—
—
—
cases:2.30%
controls:0.13%
cases:1.19%
controls:0.18%
6
19
689
6921
7
7
688
6933
—
—
—
15
9
637
6801
7
11
581
6147
Scheduled procedure
ZXD10 [2001311387]
7.5e-01
1.2e+00
1.4e+00
1.0e+50
1.9e+00
1.6e+00
1.6e+00
cases:10.07%
controls:5.03%
cases:4.46%
controls:1.43%
cases:0.86%
controls:0.22%
cases:1.44%
controls:0.00%
cases:1.04%
controls:0.16%
cases:5.67%
controls:1.15%
cases:14.46%
controls:3.46%
70
349
625
6591
31
99
664
6841
6
15
689
6925
10
0
685
6940
7
11
668
6920
37
78
615
6732
85
213
503
5945
Hypertensive heart disease without (congestive) heart failure
I11.9 [45576863]
3.4e+00
—
—
1.0e+50
—
—
3.6e+00
cases:3.88%
controls:0.13%
—
—
—
—
cases:1.87%
controls:0.00%
—
—
—
—
cases:5.95%
controls:0.18%
27
9
668
6931
—
—
13
0
682
6940
—
—
35
11
553
6147
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 [3019250]
1.1e+00
2.1e+00
—
—
—
2.8e+00
2.0e+00
cases:1.15%
controls:0.37%
cases:1.15%
controls:0.14%
—
—
—
—
—
—
cases:1.23%
controls:0.07%
cases:1.36%
controls:0.18%
8
26
687
6914
8
10
687
6930
—
—
—
8
5
644
6805
8
11
580
6147
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
5.8e-01
8.4e-01
1.7e+00
—
2.1e+00
9.0e-01
8.1e-01
cases:9.35%
controls:5.45%
cases:7.77%
controls:3.52%
cases:3.45%
controls:0.62%
—
—
cases:4.44%
controls:0.59%
cases:7.52%
controls:3.19%
cases:17.52%
controls:8.64%
65
378
630
6562
54
244
641
6696
24
43
671
6897
—
30
41
645
6890
49
217
603
6593
103
532
485
5626
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
5.1e-01
1.2e+00
1.5e+00
1.0e+50
2.3e+00
1.0e+00
9.0e-01
cases:7.77%
controls:4.83%
cases:7.63%
controls:2.33%
cases:2.16%
controls:0.48%
cases:1.29%
controls:0.00%
cases:3.85%
controls:0.42%
cases:7.06%
controls:2.67%
cases:16.33%
controls:7.37%
54
335
641
6605
53
162
642
6778
15
33
680
6907
9
0
686
6940
26
29
649
6902
46
182
606
6628
96
454
492
5704
Laboratory Visit
OMOP4822461 [32036]
1.2e-01
3.2e-01
1.5e+00
3.6e+00
1.1e+00
3.5e-01
2.4e-01
cases:25.47%
controls:23.21%
cases:27.63%
controls:21.67%
cases:23.02%
controls:6.38%
cases:8.49%
controls:0.24%
cases:16.44%
controls:6.20%
cases:30.37%
controls:23.42%
cases:47.96%
controls:42.04%
177
1611
518
5329
192
1504
503
5436
160
443
535
6497
59
17
636
6923
111
430
564
6501
198
1595
454
5215
282
2589
306
3569
Pneumonia, unspecified
J18.9 [45601123]
8.2e-01
1.1e+00
1.9e+00
—
2.6e+00
1.1e+00
1.1e+00
cases:4.17%
controls:1.87%
cases:2.73%
controls:0.91%
cases:0.86%
controls:0.13%
—
—
cases:1.19%
controls:0.09%
cases:3.07%
controls:1.04%
cases:8.16%
controls:2.97%
29
130
666
6810
19
63
676
6877
6
9
689
6931
—
8
6
667
6925
20
71
632
6739
48
183
540
5975
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 [3000515]
1.1e+00
2.2e+00
—
—
—
2.8e+00
1.7e+00
cases:1.15%
controls:0.39%
cases:1.01%
controls:0.12%
—
—
—
—
—
—
cases:1.23%
controls:0.07%
cases:1.36%
controls:0.24%
8
27
687
6913
7
8
688
6932
—
—
—
8
5
644
6805
8
15
580
6143
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
8.5e-01
1.6e+00
2.0e+00
—
3.0e+00
1.2e+00
1.0e+00
cases:2.30%
controls:0.99%
cases:2.01%
controls:0.43%
cases:0.72%
controls:0.10%
—
—
cases:1.63%
controls:0.09%
cases:1.99%
controls:0.62%
cases:4.59%
controls:1.67%
16
69
679
6871
14
30
681
6910
5
7
690
6933
—
11
6
664
6925
13
42
639
6768
27
103
561
6055
Bacteria identified in Blood by Culture
600-7 [3023368]
3.9e-01
7.9e-01
2.4e+00
1.0e+50
2.3e+00
1.2e+00
8.6e-01
cases:3.74%
controls:2.56%
cases:3.02%
controls:1.40%
cases:1.29%
controls:0.12%
cases:1.29%
controls:0.00%
cases:1.93%
controls:0.20%
cases:3.68%
controls:1.17%
cases:7.65%
controls:3.39%
26
178
669
6762
21
97
674
6843
9
8
686
6932
9
0
686
6940
13
14
662
6917
24
80
628
6730
45
209
543
5949
Reticulocytes/Erythrocytes in Blood
4679-7 [3027945]
9.7e-01
1.3e+00
—
—
2.2e+00
1.3e+00
9.2e-01
cases:2.59%
controls:0.99%
cases:1.87%
controls:0.52%
—
—
—
—
cases:0.89%
controls:0.10%
cases:1.84%
controls:0.48%
cases:4.25%
controls:1.74%
18
69
677
6871
13
36
682
6904
—
—
6
7
669
6924
12
33
640
6777
25
107
563
6051
isosorbide mononitrate; oral
C01DA14 [21600324]
9.0e-01
8.4e-01
1.6e+00
—
1.5e+00
8.9e-01
1.0e+00
cases:5.61%
controls:2.35%
cases:4.46%
controls:1.97%
cases:2.16%
controls:0.46%
—
—
cases:2.22%
controls:0.52%
cases:4.75%
controls:2.01%
cases:7.48%
controls:2.87%
39
163
656
6777
31
137
664
6803
15
32
680
6908
—
15
36
660
6895
31
137
621
6673
44
177
544
5981
Chronic kidney disease, unspecified
N18.9 [45553438]
1.9e+00
1.3e+00
—
—
—
2.6e+00
2.2e+00
cases:1.73%
controls:0.26%
cases:0.72%
controls:0.20%
—
—
—
—
—
—
cases:2.76%
controls:0.22%
cases:4.76%
controls:0.55%
12
18
683
6922
5
14
690
6926
—
—
—
18
15
634
6795
28
34
560
6124
Supplier / Service Provider
OMOP5117446 [33004]
-5.4e-01
2.0e-02
9.2e-01
—
—
3.7e+00
3.5e+00
cases:15.83%
controls:24.35%
cases:8.06%
controls:7.91%
cases:1.58%
controls:0.63%
—
—
—
—
cases:7.36%
controls:0.21%
cases:14.29%
controls:0.49%
110
1690
585
5250
56
549
639
6391
11
44
684
6896
—
—
48
14
604
6796
84
30
504
6128
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
1.4e+00
2.3e+00
—
—
—
2.2e+00
2.0e+00
cases:1.44%
controls:0.37%
cases:0.86%
controls:0.09%
—
—
—
—
—
—
cases:1.23%
controls:0.13%
cases:1.36%
controls:0.18%
10
26
685
6914
6
6
689
6934
—
—
—
8
9
644
6801
8
11
580
6147
Essential (primary) hypertension
I10 [45591453]
9.0e-01
9.6e-01
1.6e+00
—
1.3e+00
9.6e-01
8.0e-01
cases:24.75%
controls:11.74%
cases:14.10%
controls:5.94%
cases:4.60%
controls:0.92%
—
—
cases:3.41%
controls:0.94%
cases:16.10%
controls:6.87%
cases:32.99%
controls:18.07%
172
815
523
6125
98
412
597
6528
32
64
663
6876
—
23
65
652
6866
105
468
547
6342
194
1113
394
5045
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
4.4e-01
7.6e-01
2.2e+00
—
2.0e+00
7.6e-01
7.5e-01
cases:7.19%
controls:4.77%
cases:5.76%
controls:2.78%
cases:2.30%
controls:0.26%
—
—
cases:3.26%
controls:0.45%
cases:5.67%
controls:2.73%
cases:14.12%
controls:7.23%
50
331
645
6609
40
193
655
6747
16
18
679
6922
—
22
31
653
6900
37
186
615
6624
83
445
505
5713
Anaemia, unspecified
D64.9 [45600610]
1.4e+00
2.2e+00
—
—
—
1.6e+00
1.1e+00
cases:2.73%
controls:0.68%
cases:2.01%
controls:0.23%
—
—
—
—
—
—
cases:1.53%
controls:0.31%
cases:3.06%
controls:0.99%
19
47
676
6893
14
16
681
6924
—
—
—
10
21
642
6789
18
61
570
6097
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
4.6e-01
8.1e-01
2.1e+00
—
1.5e+00
1.1e+00
8.1e-01
cases:6.62%
controls:4.29%
cases:4.89%
controls:2.25%
cases:1.44%
controls:0.17%
—
—
cases:1.33%
controls:0.29%
cases:5.06%
controls:1.82%
cases:12.07%
controls:5.75%
46
298
649
6642
34
156
661
6784
10
12
685
6928
—
9
20
666
6911
33
124
619
6686
71
354
517
5804
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
4.4e-01
1.1e+00
1.4e+00
1.0e+50
2.0e+00
1.0e+00
7.8e-01
cases:8.06%
controls:5.35%
cases:7.91%
controls:2.74%
cases:2.16%
controls:0.52%
cases:1.01%
controls:0.00%
cases:3.70%
controls:0.53%
cases:7.82%
controls:2.98%
cases:17.35%
controls:8.80%
56
371
639
6569
55
190
640
6750
15
36
680
6904
7
0
688
6940
25
37
650
6894
51
203
601
6607
102
542
486
5616
Sleep apnoea
G47.3 [45562094]
4.3e-01
7.7e-01
1.9e+00
1.0e+50
1.6e+00
1.1e+00
1.0e+00
cases:4.17%
controls:2.75%
cases:4.03%
controls:1.90%
cases:1.73%
controls:0.27%
cases:1.44%
controls:0.00%
cases:1.48%
controls:0.32%
cases:5.67%
controls:1.91%
cases:9.52%
controls:3.70%
29
191
666
6749
28
132
667
6808
12
19
683
6921
10
0
685
6940
10
22
665
6909
37
130
615
6680
56
228
532
5930
Monitored bed care
WX892 [2001310850]
1.9e+00
2.2e+00
—
1.0e+50
—
—
2.2e+00
cases:2.30%
controls:0.36%
cases:1.01%
controls:0.12%
—
—
cases:0.72%
controls:0.00%
—
—
—
—
cases:3.40%
controls:0.39%
16
25
679
6915
7
8
688
6932
—
5
0
690
6940
—
—
20
24
568
6134
General Practice
1 [38004446]
6.0e-01
8.9e-01
1.4e+00
—
1.9e+00
8.7e-01
5.0e-01
cases:13.67%
controls:8.00%
cases:8.63%
controls:3.72%
cases:2.30%
controls:0.59%
—
—
cases:2.22%
controls:0.33%
cases:9.05%
controls:3.99%
cases:18.71%
controls:12.24%
95
555
600
6385
60
258
635
6682
16
41
679
6899
—
15
23
660
6908
59
272
593
6538
110
754
478
5404
Pharmacy visit
OMOP4822462 [581458]
2.9e-01
9.0e-01
7.7e-01
1.4e+00
1.2e+00
1.0e+00
9.5e-01
cases:89.64%
controls:86.67%
cases:89.35%
controls:77.32%
cases:57.84%
controls:38.95%
cases:7.48%
controls:1.99%
cases:66.81%
controls:38.77%
cases:90.80%
controls:78.31%
cases:96.94%
controls:92.48%
623
6015
72
925
621
5366
74
1574
402
2703
293
4237
52
138
643
6802
451
2687
224
4244
592
5333
60
1477
570
5695
18
463
Emergency Medicine
93 [38004510]
4.8e-01
8.7e-01
2.1e+00
—
1.4e+00
8.0e-01
5.0e-01
cases:10.36%
controls:6.69%
cases:8.63%
controls:3.82%
cases:3.17%
controls:0.39%
—
—
cases:1.93%
controls:0.50%
cases:7.21%
controls:3.38%
cases:18.54%
controls:12.11%
72
464
623
6476
60
265
635
6675
22
27
673
6913
—
13
35
662
6896
47
230
605
6580
109
746
479
5412
Differential panel, method unspecified - Blood
69738-3 [42870588]
9.2e-02
7.0e-01
1.5e+00
—
1.8e+00
1.0e+00
1.0e+00
cases:4.17%
controls:3.82%
cases:4.46%
controls:2.28%
cases:1.58%
controls:0.37%
—
—
cases:2.81%
controls:0.46%
cases:5.98%
controls:2.19%
cases:13.10%
controls:5.05%
29
265
666
6675
31
158
664
6782
11
26
684
6914
—
19
32
656
6899
39
149
613
6661
77
311
511
5847
Type 2 diabetes mellitus, with multiple complications
E11.7 [45561950]
1.4e+00
1.6e+00
—
1.0e+50
—
1.9e+00
1.2e+00
cases:1.87%
controls:0.49%
cases:1.29%
controls:0.27%
—
—
cases:0.72%
controls:0.00%
—
—
cases:1.84%
controls:0.28%
cases:2.21%
controls:0.65%
13
34
682
6906
9
19
686
6921
—
5
0
690
6940
—
12
19
640
6791
13
40
575
6118
Atrial fibrillation and flutter
I48 [45596206]
—
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
6.0e+00
—
—
—
—
cases:3.02%
controls:0.00%
cases:8.35%
controls:0.00%
cases:5.63%
controls:0.00%
cases:14.26%
controls:0.00%
cases:24.32%
controls:0.08%
—
—
21
0
674
6940
58
0
637
6940
38
0
637
6931
93
0
559
6810
143
5
445
6153
More than one and less than three hours
ZXE10 [2001311401]
6.1e-01
5.2e-01
2.2e+00
1.0e+50
—
1.6e+00
1.6e+00
cases:7.91%
controls:4.48%
cases:2.16%
controls:1.30%
cases:1.15%
controls:0.13%
cases:1.01%
controls:0.00%
—
—
cases:4.75%
controls:1.00%
cases:12.76%
controls:2.94%
55
311
640
6629
15
90
680
6850
8
9
687
6931
7
0
688
6940
—
31
68
621
6742
75
181
513
5977
Monocytes/Leukocytes in Blood
26485-3 [3019069]
2.9e-01
7.7e-01
1.5e+00
—
1.9e+00
9.2e-01
8.5e-01
cases:7.19%
controls:5.48%
cases:6.62%
controls:3.17%
cases:2.45%
controls:0.53%
—
—
cases:3.56%
controls:0.56%
cases:7.52%
controls:3.13%
cases:16.67%
controls:7.89%
50
380
645
6560
46
220
649
6720
17
37
678
6903
—
24
39
651
6892
49
213
603
6597
98
486
490
5672
Basophils/Leukocytes in Blood
30180-4 [3022096]
2.9e-01
7.5e-01
1.6e+00
—
1.9e+00
9.1e-01
8.4e-01
cases:7.19%
controls:5.48%
cases:6.47%
controls:3.16%
cases:2.45%
controls:0.52%
—
—
cases:3.56%
controls:0.56%
cases:7.36%
controls:3.10%
cases:16.67%
controls:7.94%
50
380
645
6560
45
219
650
6721
17
36
678
6904
—
24
39
651
6892
48
211
604
6599
98
489
490
5669
prednisolone; oral, parenteral
H02AB06 [21602734]
5.9e-01
9.5e-01
1.4e+00
—
1.3e+00
8.7e-01
8.4e-01
cases:12.95%
controls:7.61%
cases:8.78%
controls:3.60%
cases:2.16%
controls:0.55%
—
—
cases:2.81%
controls:0.78%
cases:8.44%
controls:3.72%
cases:18.88%
controls:9.11%
90
528
605
6412
61
250
634
6690
15
38
680
6902
—
19
54
656
6877
55
253
597
6557
111
561
477
5597
prednisolone
A07EA01 [21600653]
5.8e-01
9.5e-01
1.4e+00
—
1.3e+00
8.9e-01
8.4e-01
cases:12.95%
controls:7.67%
cases:8.78%
controls:3.60%
cases:2.16%
controls:0.56%
—
—
cases:2.81%
controls:0.78%
cases:8.59%
controls:3.72%
cases:19.05%
controls:9.21%
90
532
605
6408
61
250
634
6690
15
39
680
6901
—
19
54
656
6877
56
253
596
6557
112
567
476
5591
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
2.6e-01
7.5e-01
1.5e+00
—
1.9e+00
8.9e-01
8.1e-01
cases:7.19%
controls:5.62%
cases:6.62%
controls:3.23%
cases:2.45%
controls:0.53%
—
—
cases:3.56%
controls:0.56%
cases:7.52%
controls:3.22%
cases:17.01%
controls:8.35%
50
390
645
6550
46
224
649
6716
17
37
678
6903
—
24
39
651
6892
49
219
603
6591
100
514
488
5644
Supine thorax X-ray examination
GD1QA [2001303648]
1.3e+00
1.9e+00
—
1.0e+50
—
1.5e+00
1.1e+00
cases:2.88%
controls:0.79%
cases:2.73%
controls:0.42%
—
—
cases:1.15%
controls:0.00%
—
—
cases:2.30%
controls:0.50%
cases:5.10%
controls:1.75%
20
55
675
6885
19
29
676
6911
—
8
0
687
6940
—
15
34
637
6776
30
108
558
6050
Short blood count panel - Blood
55429-5 [40758558]
4.5e-01
8.0e-01
1.4e+00
—
1.7e+00
1.0e+00
8.9e-01
cases:4.60%
controls:3.00%
cases:3.60%
controls:1.64%
cases:1.44%
controls:0.35%
—
—
cases:1.63%
controls:0.30%
cases:4.60%
controls:1.69%
cases:8.84%
controls:3.83%
32
208
663
6732
25
114
670
6826
10
24
685
6916
—
11
21
664
6910
30
115
622
6695
52
236
536
5922
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
2.9e-01
7.5e-01
1.5e+00
—
1.8e+00
9.1e-01
8.6e-01
cases:7.19%
controls:5.49%
cases:6.47%
controls:3.17%
cases:2.30%
controls:0.53%
—
—
cases:3.56%
controls:0.58%
cases:7.36%
controls:3.11%
cases:16.84%
controls:7.91%
50
381
645
6559
45
220
650
6720
16
37
679
6903
—
24
40
651
6891
48
212
604
6598
99
487
489
5671
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
3.0e-01
7.6e-01
1.7e+00
—
1.7e+00
8.9e-01
7.8e-01
cases:7.34%
controls:5.53%
cases:6.33%
controls:3.05%
cases:2.59%
controls:0.50%
—
—
cases:3.26%
controls:0.59%
cases:7.21%
controls:3.10%
cases:16.16%
controls:8.09%
51
384
644
6556
44
212
651
6728
18
35
677
6905
—
22
41
653
6890
47
211
605
6599
95
498
493
5660
Monocytes [#/volume] in Blood
26484-6 [3001604]
3.9e-01
8.2e-01
1.4e+00
—
1.8e+00
8.7e-01
9.1e-01
cases:8.20%
controls:5.72%
cases:7.48%
controls:3.44%
cases:2.45%
controls:0.62%
—
—
cases:4.15%
controls:0.69%
cases:7.82%
controls:3.44%
cases:18.88%
controls:8.56%
57
397
638
6543
52
239
643
6701
17
43
678
6897
—
28
48
647
6883
51
234
601
6576
111
527
477
5631
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
8.8e-01
7.0e-01
2.2e+00
—
—
1.5e+00
1.2e+00
cases:4.75%
controls:2.02%
cases:2.45%
controls:1.22%
cases:0.86%
controls:0.10%
—
—
—
—
cases:3.83%
controls:0.85%
cases:7.99%
controls:2.53%
33
140
662
6800
17
85
678
6855
6
7
689
6933
—
—
25
58
627
6752
47
156
541
6002
Basophils [#/volume] in Blood
26444-0 [3006315]
3.8e-01
8.1e-01
1.4e+00
—
1.8e+00
8.4e-01
9.0e-01
cases:8.20%
controls:5.73%
cases:7.48%
controls:3.47%
cases:2.45%
controls:0.62%
—
—
cases:4.15%
controls:0.69%
cases:7.67%
controls:3.47%
cases:18.88%
controls:8.66%
57
398
638
6542
52
241
643
6699
17
43
678
6897
—
28
48
647
6883
50
236
602
6574
111
533
477
5625
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.8e-01
8.1e-01
1.4e+00
—
1.8e+00
8.0e-01
8.6e-01
cases:8.49%
controls:5.98%
cases:7.63%
controls:3.56%
cases:2.59%
controls:0.63%
—
—
cases:4.15%
controls:0.68%
cases:7.67%
controls:3.58%
cases:18.88%
controls:9.00%
59
415
636
6525
53
247
642
6693
18
44
677
6896
—
28
47
647
6884
50
244
602
6566
111
554
477
5604
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1.9e-01
3.5e-01
1.3e+00
2.7e+00
1.3e+00
3.0e-01
2.2e-01
cases:21.58%
controls:18.59%
cases:19.14%
controls:14.34%
cases:8.49%
controls:2.41%
cases:1.29%
controls:0.09%
cases:8.15%
controls:2.32%
cases:19.33%
controls:15.08%
cases:37.76%
controls:32.75%
150
1290
545
5650
133
995
562
5945
59
167
636
6773
9
6
686
6934
55
161
620
6770
126
1027
526
5783
222
2017
366
4141
allopurinol; oral, parenteral
M04AA01 [21604131]
1.3e+00
1.6e+00
1.4e+00
—
—
1.3e+00
1.5e+00
cases:5.76%
controls:1.70%
cases:5.47%
controls:1.17%
cases:1.15%
controls:0.29%
—
—
—
—
cases:4.29%
controls:1.20%
cases:9.18%
controls:2.16%
40
118
655
6822
38
81
657
6859
8
20
687
6920
—
—
28
82
624
6728
54
133
534
6025
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
6.7e-01
5.6e-01
2.4e+00
—
1.3e+00
1.5e+00
1.1e+00
cases:5.90%
controls:3.11%
cases:2.88%
controls:1.66%
cases:1.15%
controls:0.10%
—
—
cases:0.74%
controls:0.20%
cases:4.60%
controls:1.12%
cases:10.03%
controls:3.56%
41
216
654
6724
20
115
675
6825
8
7
687
6933
—
5
14
670
6917
30
76
622
6734
59
219
529
5939
Extensive CT examination of arteria pulmonalis
FB1BD [2001302407]
1.8e+00
2.2e+00
—
—
—
—
1.7e+00
cases:2.45%
controls:0.42%
cases:1.29%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.29%
17
29
678
6911
9
10
686
6930
—
—
—
—
9
18
579
6140
Eosinophils [#/volume] in Blood
26449-9 [3013115]
4.0e-01
7.8e-01
1.4e+00
—
1.8e+00
8.5e-01
8.9e-01
cases:8.63%
controls:5.95%
cases:7.48%
controls:3.59%
cases:2.59%
controls:0.68%
—
—
cases:4.30%
controls:0.76%
cases:7.98%
controls:3.57%
cases:19.39%
controls:8.98%
60
413
635
6527
52
249
643
6691
18
47
677
6893
—
29
53
646
6878
52
243
600
6567
114
553
474
5605
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
1.1e+00
1.4e+00
—
—
—
1.7e+00
1.5e+00
cases:3.31%
controls:1.11%
cases:3.17%
controls:0.81%
—
—
—
—
—
—
cases:2.45%
controls:0.47%
cases:5.61%
controls:1.36%
23
77
672
6863
22
56
673
6884
—
—
—
16
32
636
6778
33
84
555
6074
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 [3051714]
4.4e-01
1.5e+00
—
—
2.5e+00
1.6e+00
6.0e-01
cases:3.02%
controls:1.97%
cases:2.30%
controls:0.50%
—
—
—
—
cases:1.19%
controls:0.10%
cases:2.30%
controls:0.47%
cases:4.59%
controls:2.58%
21
137
674
6803
16
35
679
6905
—
—
8
7
667
6924
15
32
637
6778
27
159
561
5999
enoxaparin; parenteral
B01AB05 [21600976]
6.8e-01
1.0e+00
1.7e+00
—
2.1e+00
1.0e+00
8.1e-01
cases:6.62%
controls:3.46%
cases:3.60%
controls:1.31%
cases:1.01%
controls:0.19%
—
—
cases:1.78%
controls:0.23%
cases:2.76%
controls:1.01%
cases:7.14%
controls:3.30%
46
240
649
6700
25
91
670
6849
7
13
688
6927
—
12
16
663
6915
18
69
634
6741
42
203
546
5955
Cardiac ultrasound examination through oesophagus
FM1BE [2001303285]
2.5e+00
—
—
1.0e+50
—
—
3.1e+00
cases:3.17%
controls:0.26%
—
—
—
—
cases:0.72%
controls:0.00%
—
—
—
—
cases:3.40%
controls:0.16%
22
18
673
6922
—
—
5
0
690
6940
—
—
20
10
568
6148
Case Management Agency
251B00000X [38004193]
3.1e-01
4.0e-01
6.0e-01
3.1e+00
7.5e-01
3.8e-01
3.2e-01
cases:52.37%
controls:44.61%
cases:49.21%
controls:39.41%
cases:23.74%
controls:14.54%
cases:15.97%
controls:0.88%
cases:27.11%
controls:14.89%
cases:52.76%
controls:43.39%
cases:72.45%
controls:65.72%
364
3096
331
3844
342
2735
353
4205
165
1009
530
5931
111
61
584
6879
183
1032
492
5899
344
2955
308
3855
426
4047
162
2111
Normoblasts [#/volume] in Blood
715-3 [3021589]
3.6e-01
6.6e-01
1.7e+00
—
1.5e+00
8.2e-01
8.4e-01
cases:6.91%
controls:4.94%
cases:7.34%
controls:3.95%
cases:3.88%
controls:0.72%
—
—
cases:3.56%
controls:0.84%
cases:8.44%
controls:3.89%
cases:15.99%
controls:7.60%
48
343
647
6597
51
274
644
6666
27
50
668
6890
—
24
58
651
6873
55
265
597
6545
94
468
494
5690
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
1.9e+00
2.1e+00
—
—
—
—
1.4e+00
cases:2.88%
controls:0.43%
cases:1.29%
controls:0.16%
—
—
—
—
—
—
—
—
cases:2.89%
controls:0.70%
20
30
675
6910
9
11
686
6929
—
—
—
—
17
43
571
6115
Social worker
Z2446 [2001311559]
1.5e+00
2.4e+00
—
1.0e+50
—
—
1.5e+00
cases:1.87%
controls:0.43%
cases:1.15%
controls:0.10%
—
—
cases:0.72%
controls:0.00%
—
—
—
—
cases:1.87%
controls:0.41%
13
30
682
6910
8
7
687
6933
—
5
0
690
6940
—
—
11
25
577
6133
Emergency Room and Inpatient Visit
ERIP [262]
6.2e-01
1.4e+00
—
1.0e+50
1.9e+00
1.1e+00
9.9e-01
cases:4.32%
controls:2.36%
cases:5.61%
controls:1.38%
—
—
cases:2.88%
controls:0.00%
cases:1.33%
controls:0.20%
cases:3.68%
controls:1.25%
cases:10.54%
controls:4.21%
30
164
665
6776
39
96
656
6844
—
20
0
675
6940
9
14
666
6917
24
85
628
6725
62
259
526
5899
pH of Serum or Plasma
2753-2 [3018418]
5.2e-01
1.2e+00
1.3e+00
—
2.1e+00
1.2e+00
9.6e-01
cases:5.18%
controls:3.16%
cases:4.75%
controls:1.46%
cases:1.01%
controls:0.27%
—
—
cases:2.67%
controls:0.33%
cases:5.21%
controls:1.70%
cases:11.90%
controls:4.94%
36
219
659
6721
33
101
662
6839
7
19
688
6921
—
18
23
657
6908
34
116
618
6694
70
304
518
5854
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
3.0e-01
1.9e+00
—
—
2.3e+00
1.3e+00
1.2e+00
cases:1.29%
controls:0.97%
cases:1.58%
controls:0.24%
—
—
—
—
cases:0.89%
controls:0.09%
cases:1.07%
controls:0.31%
cases:2.89%
controls:0.93%
9
67
686
6873
11
17
684
6923
—
—
6
6
669
6925
7
21
645
6789
17
57
571
6101
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
9.0e-01
1.2e+00
2.5e+00
—
—
1.4e+00
1.4e+00
cases:1.44%
controls:0.59%
cases:1.44%
controls:0.45%
cases:0.86%
controls:0.07%
—
—
—
—
cases:1.69%
controls:0.41%
cases:3.74%
controls:0.97%
10
41
685
6899
10
31
685
6909
6
5
689
6935
—
—
11
28
641
6782
22
60
566
6098
Inpatient Visit
IP [9201]
2.7e-01
9.5e-01
1.5e+00
1.0e+50
2.0e+00
1.4e+00
8.7e-01
cases:7.34%
controls:5.72%
cases:4.89%
controls:1.96%
cases:1.01%
controls:0.22%
cases:5.76%
controls:0.00%
cases:1.48%
controls:0.20%
cases:6.44%
controls:1.63%
cases:10.88%
controls:4.89%
51
397
644
6543
34
136
661
6804
7
15
688
6925
40
0
655
6940
10
14
665
6917
42
111
610
6699
64
301
524
5857
carvedilol; oral
C07AG02 [21601700]
1.4e+00
1.3e+00
1.2e+00
—
9.5e-01
1.0e+00
1.4e+00
cases:4.17%
controls:1.02%
cases:3.31%
controls:0.94%
cases:1.01%
controls:0.30%
—
—
cases:0.74%
controls:0.29%
cases:2.91%
controls:1.04%
cases:4.76%
controls:1.25%
29
71
666
6869
23
65
672
6875
7
21
688
6919
—
5
20
670
6911
19
71
633
6739
28
77
560
6081
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
3.5e-01
8.4e-01
1.7e+00
1.0e+50
1.8e+00
6.8e-01
8.1e-01
cases:5.61%
controls:4.03%
cases:4.60%
controls:2.03%
cases:1.58%
controls:0.30%
cases:0.86%
controls:0.00%
cases:1.93%
controls:0.32%
cases:4.29%
controls:2.22%
cases:12.76%
controls:6.12%
39
280
656
6660
32
141
663
6799
11
21
684
6919
6
0
689
6940
13
22
662
6909
28
151
624
6659
75
377
513
5781
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
2.6e-01
5.9e-01
1.5e+00
—
1.8e+00
6.6e-01
5.8e-01
cases:13.09%
controls:10.40%
cases:11.65%
controls:6.83%
cases:4.89%
controls:1.18%
—
—
cases:6.22%
controls:1.13%
cases:12.58%
controls:6.92%
cases:25.85%
controls:16.30%
91
722
604
6218
81
474
614
6466
34
82
661
6858
—
42
78
633
6853
82
471
570
6339
152
1004
436
5154
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
2.8e-01
7.0e-01
1.5e+00
—
1.7e+00
7.0e-01
4.4e-01
cases:19.71%
controls:15.59%
cases:18.42%
controls:10.10%
cases:8.20%
controls:1.96%
—
—
cases:9.33%
controls:1.83%
cases:18.10%
controls:9.90%
cases:34.86%
controls:25.67%
137
1082
558
5858
128
701
567
6239
57
136
638
6804
—
63
127
612
6804
118
674
534
6136
205
1581
383
4577
Urgent procedure
ZXD05 [2001311386]
9.1e-01
1.5e+00
—
1.0e+50
—
1.7e+00
8.1e-01
cases:7.05%
controls:2.95%
cases:3.60%
controls:0.79%
—
—
cases:1.73%
controls:0.00%
—
—
cases:3.99%
controls:0.72%
cases:5.44%
controls:2.48%
49
205
646
6735
25
55
670
6885
—
12
0
683
6940
—
26
49
626
6761
32
153
556
6005
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
7.7e-01
8.2e-01
2.3e+00
1.0e+50
—
1.4e+00
1.3e+00
cases:2.16%
controls:1.01%
cases:1.29%
controls:0.58%
cases:0.86%
controls:0.09%
cases:0.72%
controls:0.00%
—
—
cases:1.99%
controls:0.51%
cases:5.78%
controls:1.61%
15
70
680
6870
9
40
686
6900
6
6
689
6934
5
0
690
6940
—
13
35
639
6775
34
99
554
6059
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5.9e-01
1.0e+00
—
—
1.9e+00
1.1e+00
9.2e-01
cases:4.75%
controls:2.68%
cases:4.75%
controls:1.74%
—
—
—
—
cases:1.33%
controls:0.20%
cases:3.68%
controls:1.29%
cases:8.16%
controls:3.43%
33
186
662
6754
33
121
662
6819
—
—
9
14
666
6917
24
88
628
6722
48
211
540
5947
Ventricular premature depolarization
I49.3 [45538386]
2.7e+00
1.0e+50
—
—
—
—
2.2e+00
cases:1.44%
controls:0.10%
cases:0.86%
controls:0.00%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.15%
10
7
685
6933
6
0
689
6940
—
—
—
—
8
9
580
6149
Iron deficiency anaemia, unspecified
D50.9 [45605373]
1.4e+00
2.1e+00
—
—
—
1.6e+00
1.4e+00
cases:1.87%
controls:0.48%
cases:1.15%
controls:0.14%
—
—
—
—
—
—
cases:1.07%
controls:0.22%
cases:2.21%
controls:0.55%
13
33
682
6907
8
10
687
6930
—
—
—
7
15
645
6795
13
34
575
6124
Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
3255-7 [3016407]
1.3e+00
2.8e+00
—
—
—
—
2.0e+00
cases:0.86%
controls:0.24%
cases:1.15%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.19%
controls:0.16%
6
17
689
6923
8
5
687
6935
—
—
—
—
7
10
581
6148
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
2.3e-01
5.6e-01
1.9e+00
—
1.4e+00
5.0e-01
3.7e-01
cases:15.97%
controls:13.14%
cases:17.84%
controls:11.04%
cases:12.52%
controls:2.10%
—
—
cases:8.74%
controls:2.21%
cases:18.56%
controls:12.13%
cases:30.61%
controls:23.32%
111
912
584
6028
124
766
571
6174
87
146
608
6794
—
59
153
616
6778
121
826
531
5984
180
1436
408
4722
Nephrology
39 [38004479]
1.4e+00
1.3e+00
—
—
1.4e+00
1.7e+00
1.7e+00
cases:2.01%
controls:0.52%
cases:1.29%
controls:0.36%
—
—
—
—
cases:0.89%
controls:0.22%
cases:2.61%
controls:0.47%
cases:4.25%
controls:0.84%
14
36
681
6904
9
25
686
6915
—
—
6
15
669
6916
17
32
635
6778
25
52
563
6106
Heart failure, unspecified
I50.9 [45576879]
—
1.0e+50
1.0e+50
1.0e+50
1.0e+50
1.0e+50
4.7e+00
—
—
cases:9.06%
controls:0.00%
cases:3.02%
controls:0.00%
cases:3.74%
controls:0.00%
cases:2.22%
controls:0.00%
cases:6.13%
controls:0.00%
cases:11.56%
controls:0.11%
—
63
0
632
6940
21
0
674
6940
26
0
669
6940
15
0
660
6931
40
0
612
6810
68
7
520
6151
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
1.6e-01
6.8e-01
1.6e+00
1.0e+50
1.4e+00
6.9e-01
4.0e-01
cases:9.50%
controls:8.24%
cases:8.06%
controls:4.24%
cases:2.73%
controls:0.58%
cases:1.15%
controls:0.00%
cases:2.37%
controls:0.61%
cases:7.98%
controls:4.17%
cases:17.86%
controls:12.68%
66
572
629
6368
56
294
639
6646
19
40
676
6900
8
0
687
6940
16
42
659
6889
52
284
600
6526
105
781
483
5377
Kidney transplant status
Z94.0 [45566477]
—
2.0e+00
—
—
—
2.4e+00
2.4e+00
—
—
cases:0.72%
controls:0.10%
—
—
—
—
—
—
cases:0.92%
controls:0.09%
cases:1.19%
controls:0.11%
—
5
7
690
6933
—
—
—
6
6
646
6804
7
7
581
6151
Measurement of heart muscle perfusion with exercise
XF655 [2001303392]
2.0e+00
—
—
—
—
—
2.6e+00
cases:1.15%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.10%
8
11
687
6929
—
—
—
—
—
8
6
580
6152
enalapril; oral, parenteral
C09AA02 [21601786]
6.6e-01
8.9e-01
1.1e+00
—
1.2e+00
7.1e-01
5.0e-01
cases:8.49%
controls:4.60%
cases:7.34%
controls:3.16%
cases:2.59%
controls:0.86%
—
—
cases:2.67%
controls:0.81%
cases:6.29%
controls:3.19%
cases:7.65%
controls:4.79%
59
319
636
6621
51
219
644
6721
18
60
677
6880
—
18
56
657
6875
41
217
611
6593
45
295
543
5863
Cathetrisation of artery
TPH07 [2001309747]
1.1e+00
1.8e+00
—
1.0e+50
—
1.7e+00
9.7e-01
cases:2.16%
controls:0.72%
cases:1.44%
controls:0.24%
—
—
cases:1.01%
controls:0.00%
—
—
cases:1.53%
controls:0.29%
cases:1.70%
controls:0.65%
15
50
680
6890
10
17
685
6923
—
7
0
688
6940
—
10
20
642
6790
10
40
578
6118
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
3.7e-01
1.9e+00
—
—
—
1.6e+00
9.8e-01
cases:1.44%
controls:0.99%
cases:1.58%
controls:0.23%
—
—
—
—
—
—
cases:1.38%
controls:0.29%
cases:3.06%
controls:1.17%
10
69
685
6871
11
16
684
6924
—
—
—
9
20
643
6790
18
72
570
6086
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
3.2e-01
6.6e-01
1.0e+00
—
1.3e+00
7.2e-01
7.8e-01
cases:9.21%
controls:6.83%
cases:8.06%
controls:4.32%
cases:3.02%
controls:1.12%
—
—
cases:3.85%
controls:1.07%
cases:8.28%
controls:4.21%
cases:19.05%
controls:9.78%
64
474
631
6466
56
300
639
6640
21
78
674
6862
—
26
74
649
6857
54
287
598
6523
112
602
476
5556
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
1.9e-01
4.2e-01
1.6e+00
—
1.5e+00
4.8e-01
4.0e-01
cases:15.83%
controls:13.47%
cases:16.12%
controls:11.20%
cases:11.22%
controls:2.39%
—
—
cases:9.19%
controls:2.22%
cases:17.33%
controls:11.50%
cases:30.61%
controls:22.88%
110
935
585
6005
112
777
583
6163
78
166
617
6774
—
62
154
613
6777
113
783
539
6027
180
1409
408
4749
Cathetrisation of vein
TPH04 [2001309597]
8.5e-01
1.1e+00
—
1.0e+50
—
1.2e+00
1.3e+00
cases:4.46%
controls:1.96%
cases:2.16%
controls:0.73%
—
—
cases:0.72%
controls:0.00%
—
—
cases:2.30%
controls:0.69%
cases:6.97%
controls:2.06%
31
136
664
6804
15
51
680
6889
—
5
0
690
6940
—
15
47
637
6763
41
127
547
6031
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
4.4e-01
—
—
—
—
2.7e+00
1.6e+00
cases:1.01%
controls:0.65%
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.07%
cases:2.04%
controls:0.41%
7
45
688
6895
—
—
—
—
7
5
645
6805
12
25
576
6133
ciclosporin; oral, parenteral
L04AD01 [21603924]
1.8e+00
1.5e+00
—
—
—
1.9e+00
2.5e+00
cases:1.15%
controls:0.19%
cases:0.72%
controls:0.16%
—
—
—
—
—
—
cases:0.92%
controls:0.13%
cases:1.36%
controls:0.11%
8
13
687
6927
5
11
690
6929
—
—
—
6
9
646
6801
8
7
580
6151
Kappa light chains.free [Mass/volume] in Serum
36916-5 [3034860]
1.3e+00
2.1e+00
—
—
2.2e+00
1.7e+00
1.1e+00
cases:0.86%
controls:0.24%
cases:1.29%
controls:0.16%
—
—
—
—
cases:0.89%
controls:0.10%
cases:0.92%
controls:0.18%
cases:1.02%
controls:0.36%
6
17
689
6923
9
11
686
6929
—
—
6
7
669
6924
6
12
646
6798
6
22
582
6136
Lambda light chains.free [Mass/volume] in Serum or Plasma
33944-0 [3047169]
1.3e+00
2.1e+00
—
—
2.2e+00
1.7e+00
1.1e+00
cases:0.86%
controls:0.24%
cases:1.29%
controls:0.16%
—
—
—
—
cases:0.89%
controls:0.10%
cases:0.92%
controls:0.18%
cases:1.02%
controls:0.36%
6
17
689
6923
9
11
686
6929
—
—
6
7
669
6924
6
12
646
6798
6
22
582
6136
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
1.0e+00
9.6e-01
—
—
1.3e+00
1.1e+00
1.1e+00
cases:3.60%
controls:1.30%
cases:2.30%
controls:0.89%
—
—
—
—
cases:0.74%
controls:0.20%
cases:2.30%
controls:0.76%
cases:4.93%
controls:1.62%
25
90
670
6850
16
62
679
6878
—
—
5
14
670
6917
15
52
637
6758
29
100
559
6058
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
8.8e-01
1.3e+00
—
—
1.9e+00
1.1e+00
9.5e-01
cases:6.62%
controls:2.87%
cases:3.17%
controls:0.85%
—
—
—
—
cases:0.74%
controls:0.12%
cases:2.76%
controls:0.94%
cases:7.14%
controls:2.89%
46
199
649
6741
22
59
673
6881
—
—
5
8
670
6923
18
64
634
6746
42
178
546
5980
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
6.8e-01
8.3e-01
2.7e+00
—
1.7e+00
6.0e-01
4.8e-01
cases:5.47%
controls:2.85%
cases:3.31%
controls:1.47%
cases:1.73%
controls:0.12%
—
—
cases:0.74%
controls:0.13%
cases:2.15%
controls:1.19%
cases:7.82%
controls:5.00%
38
198
657
6742
23
102
672
6838
12
8
683
6932
—
5
9
670
6922
14
81
638
6729
46
308
542
5850
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
-6.8e-03
6.1e-01
1.6e+00
1.0e+50
1.4e+00
5.8e-01
3.7e-01
cases:9.06%
controls:9.12%
cases:8.35%
controls:4.70%
cases:2.73%
controls:0.59%
cases:1.15%
controls:0.00%
cases:2.81%
controls:0.69%
cases:7.98%
controls:4.61%
cases:18.54%
controls:13.58%
63
633
632
6307
58
326
637
6614
19
41
676
6899
8
0
687
6940
19
48
656
6883
52
314
600
6496
109
836
479
5322
Abdominal ultrasound examination
JN3AE [2001305555]
4.8e-01
1.5e+00
—
—
—
1.5e+00
1.2e+00
cases:1.87%
controls:1.17%
cases:1.44%
controls:0.33%
—
—
—
—
—
—
cases:1.38%
controls:0.32%
cases:4.08%
controls:1.23%
13
81
682
6859
10
23
685
6917
—
—
—
9
22
643
6788
24
76
564
6082
Type 2 diabetes mellitus, with unspecified complications
E11.8 [45561951]
9.5e-01
1.5e+00
-1.0e+50
—
—
1.6e+00
9.6e-01
cases:1.58%
controls:0.62%
cases:1.73%
controls:0.40%
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.99%
controls:0.40%
cases:3.57%
controls:1.40%
11
43
684
6897
12
28
683
6912
0
6
695
6934
—
—
13
27
639
6783
21
86
567
6072
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
2.6e-01
7.2e-01
1.6e+00
1.0e+50
1.6e+00
6.2e-01
7.7e-01
cases:4.46%
controls:3.49%
cases:3.60%
controls:1.79%
cases:1.29%
controls:0.26%
cases:0.86%
controls:0.00%
cases:1.63%
controls:0.32%
cases:3.53%
controls:1.94%
cases:11.22%
controls:5.52%
31
242
664
6698
25
124
670
6816
9
18
686
6922
6
0
689
6940
11
22
664
6909
23
132
629
6678
66
340
522
5818
atorvastatin; oral
C10AA05 [21601860]
6.6e-01
8.1e-01
7.0e-01
—
1.1e+00
8.2e-01
6.1e-01
cases:13.38%
controls:7.38%
cases:12.66%
controls:6.08%
cases:3.31%
controls:1.67%
—
—
cases:5.19%
controls:1.79%
cases:14.26%
controls:6.86%
cases:18.54%
controls:11.03%
93
512
602
6428
88
422
607
6518
23
116
672
6824
—
35
124
640
6807
93
467
559
6343
109
679
479
5479
Thrombin time
3243-3 [3036489]
8.9e-01
2.4e+00
—
—
—
—
1.6e+00
cases:1.15%
controls:0.48%
cases:1.58%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.32%
8
33
687
6907
11
10
684
6930
—
—
—
—
9
20
579
6138
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2.9e-01
7.4e-01
1.9e+00
—
1.4e+00
5.7e-01
8.5e-02
cases:9.93%
controls:7.59%
cases:7.19%
controls:3.56%
cases:2.45%
controls:0.39%
—
—
cases:1.93%
controls:0.50%
cases:6.29%
controls:3.67%
cases:13.10%
controls:12.16%
69
527
626
6413
50
247
645
6693
17
27
678
6913
—
13
35
662
6896
41
250
611
6560
77
749
511
5409
Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
14928-6 [3026989]
4.8e-01
1.5e+00
—
—
—
2.3e+00
1.7e+00
cases:0.72%
controls:0.45%
cases:1.01%
controls:0.23%
—
—
—
—
—
—
cases:1.84%
controls:0.19%
cases:3.23%
controls:0.63%
5
31
690
6909
7
16
688
6924
—
—
—
12
13
640
6797
19
39
569
6119
Heart failure
I50 [45581779]
1.0e+50
—
1.0e+50
—
—
—
3.9e+00
cases:5.18%
controls:0.00%
—
—
cases:0.72%
controls:0.00%
—
—
—
—
—
—
cases:4.59%
controls:0.10%
36
0
659
6940
—
5
0
690
6940
—
—
—
27
6
561
6152
Atrial fibrillation/flutter
K78 [2002000605]
—
—
—
—
—
—
3.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:4.42%
controls:0.10%
—
—
—
—
—
—
26
6
562
6152
Telehealth
OMOP5556618 [722455]
1.4e-01
7.1e-01
9.6e-01
-1.0e+50
1.1e+00
5.6e-01
5.6e-01
cases:16.26%
controls:14.47%
cases:11.80%
controls:6.17%
cases:3.02%
controls:1.18%
cases:0.00%
controls:0.07%
cases:2.96%
controls:1.04%
cases:12.27%
controls:7.37%
cases:29.08%
controls:19.00%
113
1004
582
5936
82
428
613
6512
21
82
674
6858
0
5
695
6935
20
72
655
6859
80
502
572
6308
171
1170
417
4988
Telephone, letter or other consultation without direct patient contact
ZY020 [2001311600]
—
—
-1.0e+50
—
—
2.2e+00
1.6e+00
—
—
—
—
cases:0.00%
controls:0.07%
—
—
—
—
cases:1.23%
controls:0.13%
cases:2.38%
controls:0.50%
—
—
0
5
695
6935
—
—
8
9
644
6801
14
31
574
6127
More than three and less than five hours
ZXE20 [2001311408]
9.7e-01
—
—
—
—
1.6e+00
1.2e+00
cases:2.88%
controls:1.11%
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.28%
cases:3.57%
controls:1.07%
20
77
675
6863
—
—
—
—
9
19
643
6791
21
66
567
6092
Hyperlipidaemia, unspecified
E78.5 [45537986]
1.2e+00
7.4e-01
-1.0e+50
1.0e+50
—
1.5e+00
1.1e+00
cases:2.16%
controls:0.68%
cases:0.72%
controls:0.35%
cases:0.00%
controls:0.07%
cases:0.86%
controls:0.00%
—
—
cases:1.69%
controls:0.38%
cases:3.74%
controls:1.23%
15
47
680
6893
5
24
690
6916
0
5
695
6935
6
0
689
6940
—
11
26
641
6784
22
76
566
6082
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
1.3e-01
4.2e-01
1.5e+00
—
1.4e+00
4.0e-01
1.7e-01
cases:17.55%
controls:15.76%
cases:17.70%
controls:12.36%
cases:10.65%
controls:2.49%
—
—
cases:9.33%
controls:2.40%
cases:18.56%
controls:13.27%
cases:31.63%
controls:28.04%
122
1094
573
5846
123
858
572
6082
74
173
621
6767
—
63
166
612
6765
121
904
531
5906
186
1727
402
4431
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 [3048773]
1.3e-01
5.7e-01
1.4e+00
—
1.4e+00
4.4e-01
2.5e-01
cases:17.27%
controls:15.46%
cases:13.67%
controls:8.21%
cases:3.60%
controls:0.92%
—
—
cases:3.70%
controls:0.95%
cases:12.88%
controls:8.66%
cases:30.10%
controls:25.15%
120
1073
575
5867
95
570
600
6370
25
64
670
6876
—
25
66
650
6865
84
590
568
6220
177
1549
411
4609
Measurement of bone density from two or more locations with X-ray
NK6QA [2001308500]
1.0e+00
2.0e+00
—
—
—
1.6e+00
1.8e+00
cases:1.44%
controls:0.52%
cases:0.86%
controls:0.12%
—
—
—
—
—
—
cases:0.92%
controls:0.19%
cases:2.04%
controls:0.36%
10
36
685
6904
6
8
689
6932
—
—
—
6
13
646
6797
12
22
576
6136
sulfamethoxazole and trimethoprim
J01EE01 [21602961]
7.6e-01
1.3e+00
—
—
—
2.0e+00
1.8e+00
cases:1.01%
controls:0.48%
cases:0.72%
controls:0.20%
—
—
—
—
—
—
cases:1.99%
controls:0.28%
cases:2.55%
controls:0.44%
7
33
688
6907
5
14
690
6926
—
—
—
13
19
639
6791
15
27
573
6131
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
1.4e-01
7.1e-01
1.6e+00
—
1.4e+00
3.7e-01
1.7e-01
cases:10.94%
controls:9.68%
cases:10.07%
controls:5.20%
cases:2.30%
controls:0.46%
—
—
cases:2.67%
controls:0.66%
cases:7.36%
controls:5.23%
cases:20.07%
controls:17.42%
76
672
619
6268
70
361
625
6579
16
32
679
6908
—
18
46
657
6885
48
356
604
6454
118
1073
470
5085
Leukocytes [#/volume] in Urine
30405-5 [3018095]
1.9e-01
6.1e-01
1.6e+00
1.0e+50
1.5e+00
5.3e-01
6.3e-01
cases:4.60%
controls:3.85%
cases:3.74%
controls:2.07%
cases:1.29%
controls:0.27%
cases:0.86%
controls:0.00%
cases:1.63%
controls:0.36%
cases:3.99%
controls:2.39%
cases:11.90%
controls:6.74%
32
267
663
6673
26
144
669
6796
9
19
686
6921
6
0
689
6940
11
25
664
6906
26
163
626
6647
70
415
518
5743
pantoprazole; oral, parenteral
A02BC02 [21600097]
4.0e-01
6.7e-01
4.6e-01
-1.0e+50
1.2e+00
8.3e-01
5.6e-01
cases:16.40%
controls:11.61%
cases:12.81%
controls:6.97%
cases:2.59%
controls:1.66%
cases:0.00%
controls:0.12%
cases:4.44%
controls:1.36%
cases:14.88%
controls:7.11%
cases:23.98%
controls:15.31%
114
806
581
6134
89
484
606
6456
18
115
677
6825
0
8
695
6932
30
94
645
6837
97
484
555
6326
141
943
447
5215
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
1.4e-01
6.3e-01
1.7e+00
—
1.9e+00
5.8e-01
3.5e-01
cases:3.45%
controls:3.03%
cases:3.31%
controls:1.79%
cases:1.29%
controls:0.23%
—
—
cases:1.63%
controls:0.25%
cases:3.22%
controls:1.84%
cases:7.99%
controls:5.78%
24
210
671
6730
23
124
672
6816
9
16
686
6924
—
11
17
664
6914
21
125
631
6685
47
356
541
5802
cefalexin; oral
J01DB01 [21602870]
3.4e-01
5.1e-01
3.8e-01
—
1.4e+00
7.4e-01
5.6e-01
cases:30.22%
controls:23.60%
cases:12.09%
controls:7.61%
cases:1.29%
controls:0.89%
—
—
cases:2.67%
controls:0.66%
cases:13.04%
controls:6.70%
cases:35.20%
controls:23.68%
210
1638
485
5302
84
528
611
6412
9
62
686
6878
—
18
46
657
6885
85
456
567
6354
207
1458
381
4700
losartan; oral
C09CA01 [21601824]
5.8e-01
7.1e-01
8.1e-01
—
1.1e+00
6.3e-01
5.6e-01
cases:7.05%
controls:4.06%
cases:7.34%
controls:3.75%
cases:2.59%
controls:1.17%
—
—
cases:2.96%
controls:1.04%
cases:7.52%
controls:4.16%
cases:10.88%
controls:6.50%
49
282
646
6658
51
260
644
6680
18
81
677
6859
—
20
72
655
6859
49
283
603
6527
64
400
524
5758
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
5.2e-01
6.6e-01
2.0e+00
—
2.6e+00
2.4e-01
8.1e-01
cases:3.74%
controls:2.26%
cases:2.01%
controls:1.05%
cases:0.72%
controls:0.10%
—
—
cases:1.19%
controls:0.09%
cases:1.38%
controls:1.09%
cases:6.46%
controls:2.97%
26
157
669
6783
14
73
681
6867
5
7
690
6933
—
8
6
667
6925
9
74
643
6736
38
183
550
5975
General anesthesia, balanced
WX408 [2001310808]
7.2e-01
9.9e-01
—
1.0e+50
—
1.6e+00
1.1e+00
cases:5.47%
controls:2.74%
cases:1.87%
controls:0.71%
—
—
cases:0.72%
controls:0.00%
—
—
cases:3.07%
controls:0.63%
cases:6.29%
controls:2.19%
38
190
657
6750
13
49
682
6891
—
5
0
690
6940
—
20
43
632
6767
37
135
551
6023
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
1.1e+00
9.5e-01
—
—
—
1.6e+00
7.5e-01
cases:4.32%
controls:1.50%
cases:1.58%
controls:0.62%
—
—
—
—
—
—
cases:2.61%
controls:0.56%
cases:4.42%
controls:2.14%
30
104
665
6836
11
43
684
6897
—
—
—
17
38
635
6772
26
132
562
6026
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
1.8e-01
7.0e-01
1.2e+00
—
1.5e+00
4.7e-01
2.6e-01
cases:11.37%
controls:9.71%
cases:10.07%
controls:5.27%
cases:2.30%
controls:0.68%
—
—
cases:2.67%
controls:0.63%
cases:8.28%
controls:5.35%
cases:19.56%
controls:15.80%
79
674
616
6266
70
366
625
6574
16
47
679
6893
—
18
44
657
6887
54
364
598
6446
115
973
473
5185
Oxygen saturation in Arterial blood
2708-6 [3016502]
6.8e-01
1.7e+00
—
—
1.0e+50
1.6e+00
7.8e-01
cases:1.29%
controls:0.66%
cases:2.30%
controls:0.42%
—
—
—
—
cases:0.74%
controls:0.00%
cases:1.69%
controls:0.34%
cases:2.55%
controls:1.19%
9
46
686
6894
16
29
679
6911
—
—
5
0
670
6931
11
23
641
6787
15
73
573
6085
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
-1.1e-02
5.3e-01
1.2e+00
1.0e+50
1.4e+00
5.9e-01
3.0e-01
cases:4.75%
controls:4.80%
cases:5.18%
controls:3.11%
cases:1.73%
controls:0.50%
cases:0.86%
controls:0.00%
cases:1.93%
controls:0.46%
cases:6.13%
controls:3.49%
cases:14.12%
controls:10.90%
33
333
662
6607
36
216
659
6724
12
35
683
6905
6
0
689
6940
13
32
662
6899
40
238
612
6572
83
671
505
5487
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
206 [2001600204]
7.0e-01
1.8e+00
—
—
—
1.5e+00
5.3e-01
cases:3.17%
controls:1.60%
cases:2.16%
controls:0.36%
—
—
—
—
—
—
cases:1.69%
controls:0.40%
cases:2.21%
controls:1.32%
22
111
673
6829
15
25
680
6915
—
—
—
11
27
641
6783
13
81
575
6077
Base excess in Arterial blood by calculation
1925-7 [3003396]
9.6e-01
1.7e+00
—
—
1.0e+50
1.6e+00
8.3e-01
cases:2.01%
controls:0.78%
cases:2.45%
controls:0.46%
—
—
—
—
cases:1.19%
controls:0.00%
cases:1.99%
controls:0.43%
cases:2.89%
controls:1.28%
14
54
681
6886
17
32
678
6908
—
—
8
0
667
6931
13
29
639
6781
17
79
571
6079
Cardiac arrhythmia NOS
K80 [2002000607]
1.7e+00
—
—
—
—
1.7e+00
1.5e+00
cases:1.44%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.15%
cases:2.04%
controls:0.45%
10
18
685
6922
—
—
—
—
5
10
647
6800
12
28
576
6130
Old myocardial infarction
I25.2 [45601025]
1.1e+00
—
—
1.0e+50
—
1.7e+00
1.6e+00
cases:1.44%
controls:0.48%
—
—
—
—
cases:0.86%
controls:0.00%
—
—
cases:1.23%
controls:0.23%
cases:2.72%
controls:0.58%
10
33
685
6907
—
—
6
0
689
6940
—
8
16
644
6794
16
36
572
6122
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
7.0e-01
8.1e-01
9.2e-01
—
1.2e+00
8.8e-01
8.3e-01
cases:7.34%
controls:3.79%
cases:4.89%
controls:2.25%
cases:1.15%
controls:0.46%
—
—
cases:1.19%
controls:0.38%
cases:5.21%
controls:2.23%
cases:12.41%
controls:5.80%
51
263
644
6677
34
156
661
6784
8
32
687
6908
—
8
26
667
6905
34
152
618
6658
73
357
515
5801
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
9.8e-01
1.7e+00
—
—
1.0e+50
1.6e+00
7.8e-01
cases:2.01%
controls:0.76%
cases:2.45%
controls:0.48%
—
—
—
—
cases:1.19%
controls:0.00%
cases:1.99%
controls:0.43%
cases:2.72%
controls:1.27%
14
53
681
6887
17
33
678
6907
—
—
8
0
667
6931
13
29
639
6781
16
78
572
6080
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
9.8e-01
1.7e+00
—
—
1.0e+50
1.6e+00
7.8e-01
cases:2.01%
controls:0.76%
cases:2.45%
controls:0.48%
—
—
—
—
cases:1.19%
controls:0.00%
cases:1.99%
controls:0.43%
cases:2.72%
controls:1.27%
14
53
681
6887
17
33
678
6907
—
—
8
0
667
6931
13
29
639
6781
16
78
572
6080
azathioprine; oral, parenteral
L04AX01 [21603927]
1.3e+00
1.6e+00
—
—
—
1.6e+00
1.6e+00
cases:1.15%
controls:0.30%
cases:1.15%
controls:0.23%
—
—
—
—
—
—
cases:1.07%
controls:0.22%
cases:1.70%
controls:0.36%
8
21
687
6919
8
16
687
6924
—
—
—
7
15
645
6795
10
22
578
6136
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
3.3e-01
1.4e+00
—
—
—
1.7e+00
8.1e-01
cases:0.86%
controls:0.62%
cases:1.58%
controls:0.39%
—
—
—
—
—
—
cases:1.69%
controls:0.31%
cases:2.38%
controls:1.07%
6
43
689
6897
11
27
684
6913
—
—
—
11
21
641
6789
14
66
574
6092
Intravenous
ZX120 [2001311495]
1.4e+00
1.7e+00
—
—
—
1.2e+00
8.8e-01
cases:2.01%
controls:0.50%
cases:1.73%
controls:0.32%
—
—
—
—
—
—
cases:1.23%
controls:0.37%
cases:2.21%
controls:0.93%
14
35
681
6905
12
22
683
6918
—
—
—
8
25
644
6785
13
57
575
6101
dapagliflozin; oral
A10BK01 [1123890]
—
1.0e+00
—
—
1.9e+00
1.9e+00
1.2e+00
—
—
cases:0.72%
controls:0.26%
—
—
—
—
cases:0.74%
controls:0.12%
cases:1.99%
controls:0.29%
cases:2.38%
controls:0.75%
—
5
18
690
6922
—
—
5
8
670
6923
13
20
639
6790
14
46
574
6112
pH of Arterial blood
2744-1 [3019977]
8.1e-01
1.7e+00
—
—
1.0e+50
1.4e+00
8.0e-01
cases:1.73%
controls:0.78%
cases:2.45%
controls:0.48%
—
—
—
—
cases:1.19%
controls:0.00%
cases:1.84%
controls:0.44%
cases:2.89%
controls:1.32%
12
54
683
6886
17
33
678
6907
—
—
8
0
667
6931
12
30
640
6780
17
81
571
6077
Sequelae of cerebral infarction
I69.3 [45533476]
7.0e-01
1.4e+00
—
—
—
1.7e+00
9.8e-01
cases:1.15%
controls:0.58%
cases:1.44%
controls:0.36%
—
—
—
—
—
—
cases:1.69%
controls:0.32%
cases:2.55%
controls:0.97%
8
40
687
6900
10
25
685
6915
—
—
—
11
22
641
6788
15
60
573
6098
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
4.6e-01
9.5e-01
2.3e+00
—
1.6e+00
9.6e-01
7.2e-01
cases:3.02%
controls:1.93%
cases:1.87%
controls:0.73%
cases:1.15%
controls:0.12%
—
—
cases:0.74%
controls:0.14%
cases:2.15%
controls:0.84%
cases:5.44%
controls:2.71%
21
134
674
6806
13
51
682
6889
8
8
687
6932
—
5
10
670
6921
14
57
638
6753
32
167
556
5991
Endocrinology
46 [38004485]
5.5e-01
9.7e-01
—
—
1.5e+00
9.4e-01
1.1e+00
cases:3.31%
controls:1.95%
cases:2.59%
controls:0.99%
—
—
—
—
cases:0.74%
controls:0.16%
cases:3.07%
controls:1.22%
cases:6.46%
controls:2.22%
23
135
672
6805
18
69
677
6871
—
—
5
11
670
6920
20
83
632
6727
38
137
550
6021
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
2.2e-01
5.9e-01
1.0e+00
—
1.4e+00
3.3e-01
2.1e-01
cases:16.40%
controls:13.60%
cases:13.53%
controls:8.00%
cases:2.88%
controls:1.04%
—
—
cases:3.85%
controls:1.00%
cases:11.04%
controls:8.21%
cases:27.89%
controls:23.86%
114
944
581
5996
94
555
601
6385
20
72
675
6868
—
26
69
649
6862
72
559
580
6251
164
1469
424
4689
Lysozyme [Mass/volume] in Serum or Plasma
2589-0 [3012110]
1.5e+00
3.0e+00
—
—
—
—
1.5e+00
cases:0.86%
controls:0.19%
cases:1.44%
controls:0.07%
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.29%
6
13
689
6927
10
5
685
6935
—
—
—
—
8
18
580
6140
amoxicillin; oral, parenteral
J01CA04 [21602823]
4.6e-01
7.0e-01
5.8e-01
—
7.5e-01
8.9e-01
8.5e-01
cases:23.60%
controls:16.33%
cases:9.50%
controls:4.96%
cases:1.15%
controls:0.65%
—
—
cases:1.33%
controls:0.63%
cases:11.81%
controls:5.21%
cases:33.33%
controls:17.59%
164
1133
531
5807
66
344
629
6596
8
45
687
6895
—
9
44
666
6887
77
355
575
6455
196
1083
392
5075
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 [3023602]
1.4e-01
5.2e-01
1.2e+00
—
1.1e+00
3.5e-01
2.2e-01
cases:18.13%
controls:16.12%
cases:14.96%
controls:9.48%
cases:3.74%
controls:1.12%
—
—
cases:3.41%
controls:1.11%
cases:14.26%
controls:10.46%
cases:32.82%
controls:28.14%
126
1119
569
5821
104
658
591
6282
26
78
669
6862
—
23
77
652
6854
93
712
559
6098
193
1733
395
4425
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.5e-01
5.1e-01
1.2e+00
—
1.2e+00
3.0e-01
1.9e-01
cases:18.71%
controls:16.50%
cases:15.40%
controls:9.83%
cases:3.74%
controls:1.17%
—
—
cases:3.70%
controls:1.17%
cases:14.26%
controls:10.94%
cases:32.99%
controls:28.91%
130
1145
565
5795
107
682
588
6258
26
81
669
6859
—
25
81
650
6850
93
745
559
6065
194
1780
394
4378
Cerebral infarction, unspecified
I63.9 [45596216]
1.1e+00
1.8e+00
—
—
—
1.1e+00
4.1e-01
cases:2.30%
controls:0.78%
cases:1.44%
controls:0.24%
—
—
—
—
—
—
cases:1.07%
controls:0.35%
cases:1.87%
controls:1.25%
16
54
679
6886
10
17
685
6923
—
—
—
7
24
645
6786
11
77
577
6081
Bradycardia, unspecified
R00.1 [45539313]
—
—
—
—
—
—
2.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.11%
—
—
—
—
—
—
11
7
577
6151
Bacteria identified in Skin by Aerobe culture
620-5 [3007853]
6.5e-01
8.3e-01
—
—
—
1.7e+00
1.1e+00
cases:2.30%
controls:1.21%
cases:1.15%
controls:0.50%
—
—
—
—
—
—
cases:1.23%
controls:0.23%
cases:4.08%
controls:1.33%
16
84
679
6856
8
35
687
6905
—
—
—
8
16
644
6794
24
82
564
6076
Chronic hypertension
205 [2001600203]
5.0e-01
—
—
—
—
1.8e+00
1.0e+00
cases:3.45%
controls:2.12%
—
—
—
—
—
—
—
—
cases:1.69%
controls:0.28%
cases:2.89%
controls:1.09%
24
147
671
6793
—
—
—
—
11
19
641
6791
17
67
571
6091
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
1.4e-01
4.0e-01
1.2e+00
—
1.2e+00
2.2e-01
1.5e-01
cases:18.56%
controls:16.57%
cases:13.96%
controls:9.80%
cases:3.88%
controls:1.24%
—
—
cases:3.70%
controls:1.13%
cases:13.04%
controls:10.78%
cases:31.63%
controls:28.53%
129
1150
566
5790
97
680
598
6260
27
86
668
6854
—
25
78
650
6853
85
734
567
6076
186
1757
402
4401
Shortness of breath/dyspnoea
R02 [2002000883]
9.6e-01
1.5e+00
—
—
—
1.2e+00
1.3e+00
cases:2.01%
controls:0.78%
cases:1.58%
controls:0.36%
—
—
—
—
—
—
cases:0.77%
controls:0.23%
cases:3.23%
controls:0.93%
14
54
681
6886
11
25
684
6915
—
—
—
5
16
647
6794
19
57
569
6101
Bacteria [Presence] in Urine
87829-8 [36304419]
2.7e-01
6.9e-01
—
—
1.9e+00
5.2e-01
8.5e-01
cases:3.74%
controls:2.88%
cases:3.02%
controls:1.54%
—
—
—
—
cases:1.63%
controls:0.25%
cases:2.61%
controls:1.57%
cases:9.69%
controls:4.40%
26
200
669
6740
21
107
674
6833
—
—
11
17
664
6914
17
107
635
6703
57
271
531
5887
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
8.1e-03
5.3e-01
1.3e+00
1.0e+50
1.5e+00
5.7e-01
3.2e-01
cases:4.75%
controls:4.71%
cases:5.04%
controls:3.03%
cases:1.73%
controls:0.49%
cases:0.86%
controls:0.00%
cases:1.93%
controls:0.45%
cases:5.98%
controls:3.47%
cases:14.12%
controls:10.65%
33
327
662
6613
35
210
660
6730
12
34
683
6906
6
0
689
6940
13
31
662
6900
39
236
613
6574
83
656
505
5502
Sarcoidosis of lung
D86.0 [45576422]
2.7e+00
—
—
—
—
—
—
cases:1.29%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
9
6
686
6934
—
—
—
—
—
—
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
8.4e-01
1.2e+00
—
—
—
1.8e+00
9.2e-01
cases:1.29%
controls:0.56%
cases:1.01%
controls:0.32%
—
—
—
—
—
—
cases:1.53%
controls:0.26%
cases:3.23%
controls:1.32%
9
39
686
6901
7
22
688
6918
—
—
—
10
18
642
6792
19
81
569
6077
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
-7.7e-03
5.2e-01
1.2e+00
1.0e+50
1.4e+00
5.6e-01
3.1e-01
cases:4.89%
controls:4.93%
cases:5.18%
controls:3.16%
cases:1.73%
controls:0.50%
cases:0.86%
controls:0.00%
cases:1.93%
controls:0.46%
cases:6.13%
controls:3.58%
cases:14.29%
controls:10.88%
34
342
661
6598
36
219
659
6721
12
35
683
6905
6
0
689
6940
13
32
662
6899
40
244
612
6566
84
670
504
5488
dabigatran etexilate; oral
B01AE07 [21601026]
2.1e+00
—
1.0e+50
—
—
—
2.7e+00
cases:0.72%
controls:0.09%
—
—
cases:0.72%
controls:0.00%
—
—
—
—
—
—
cases:1.87%
controls:0.13%
5
6
690
6934
—
5
0
690
6940
—
—
—
11
8
577
6150
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
1.4e+00
—
—
—
—
1.1e+00
1.2e+00
cases:2.30%
controls:0.56%
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.41%
cases:3.06%
controls:0.91%
16
39
679
6901
—
—
—
—
8
28
644
6782
18
56
570
6102
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 [3001308]
1.4e-01
4.1e-01
1.2e+00
—
1.1e+00
2.4e-01
1.6e-01
cases:19.42%
controls:17.28%
cases:15.83%
controls:11.11%
cases:4.17%
controls:1.34%
—
—
cases:3.56%
controls:1.23%
cases:15.34%
controls:12.45%
cases:34.69%
controls:31.07%
135
1199
560
5741
110
771
585
6169
29
93
666
6847
—
24
85
651
6846
100
848
552
5962
204
1913
384
4245
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83 [45552036]
7.6e-01
—
—
—
—
2.6e+00
—
cases:1.01%
controls:0.48%
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.09%
—
—
7
33
688
6907
—
—
—
—
8
6
644
6804
—
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
2.8e-01
6.0e-01
—
—
1.8e+00
4.7e-01
8.3e-01
cases:4.03%
controls:3.07%
cases:2.88%
controls:1.60%
—
—
—
—
cases:1.63%
controls:0.27%
cases:2.76%
controls:1.75%
cases:10.20%
controls:4.74%
28
213
667
6727
20
111
675
6829
—
—
11
19
664
6912
18
119
634
6691
60
292
528
5866
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
7.4e-01
8.8e-01
—
—
—
1.4e+00
1.2e+00
cases:1.44%
controls:0.69%
cases:0.86%
controls:0.36%
—
—
—
—
—
—
cases:1.53%
controls:0.37%
cases:3.74%
controls:1.19%
10
48
685
6892
6
25
689
6915
—
—
—
10
25
642
6785
22
73
566
6085
Urate [Moles/volume] in Serum or Plasma
14933-6 [3026493]
2.5e-01
7.0e-01
2.0e+00
—
—
6.1e-01
6.6e-01
cases:3.45%
controls:2.71%
cases:2.30%
controls:1.15%
cases:1.01%
controls:0.14%
—
—
—
—
cases:2.30%
controls:1.26%
cases:8.16%
controls:4.38%
24
188
671
6752
16
80
679
6860
7
10
688
6930
—
—
15
86
637
6724
48
270
540
5888
Intravenous general anesthesia
WX404 [2001310807]
6.6e-01
7.6e-01
—
—
—
1.3e+00
1.3e+00
cases:3.45%
controls:1.82%
cases:1.01%
controls:0.48%
—
—
—
—
—
—
cases:1.69%
controls:0.46%
cases:5.10%
controls:1.46%
24
126
671
6814
7
33
688
6907
—
—
—
11
31
641
6779
30
90
558
6068
Sedation and analgesia
WX002 [2001310758]
3.2e-01
4.2e-01
—
—
—
1.4e+00
1.2e+00
cases:2.88%
controls:2.10%
cases:0.72%
controls:0.48%
—
—
—
—
—
—
cases:1.53%
controls:0.40%
cases:5.78%
controls:1.74%
20
146
675
6794
5
33
690
6907
—
—
—
10
27
642
6783
34
107
554
6051
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
FXA00 [2001303347]
2.6e+00
—
—
—
—
—
—
cases:1.15%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
8
6
687
6934
—
—
—
—
—
—
glyceryl trinitrate; local oral, oral, sublingual, transdermal
C01DA02 [21600317]
3.6e-01
8.8e-01
—
—
1.6e+00
9.1e-01
8.1e-01
cases:5.76%
controls:4.09%
cases:4.46%
controls:1.90%
—
—
—
—
cases:1.19%
controls:0.25%
cases:4.91%
controls:2.04%
cases:9.01%
controls:4.22%
40
284
655
6656
31
132
664
6808
—
—
8
17
667
6914
32
139
620
6671
53
260
535
5898
Bacterial pneumonia, unspecified
J15.9 [45557621]
1.1e+00
—
—
—
—
1.8e+00
1.5e+00
cases:2.01%
controls:0.66%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.13%
cases:2.55%
controls:0.60%
14
46
681
6894
—
—
—
—
5
9
647
6801
15
37
573
6121
amlodipine; oral
C08CA01 [21601747]
6.1e-01
5.4e-01
3.0e-01
—
8.7e-01
5.5e-01
4.0e-01
cases:12.66%
controls:7.31%
cases:10.50%
controls:6.38%
cases:2.73%
controls:2.03%
—
—
cases:4.00%
controls:1.72%
cases:11.66%
controls:7.08%
cases:14.63%
controls:10.28%
88
507
607
6433
73
443
622
6497
19
141
676
6799
—
27
119
648
6812
76
482
576
6328
86
633
502
5525
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
1.5e+00
—
—
—
—
1.6e+00
1.1e+00
cases:1.73%
controls:0.40%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.19%
cases:2.21%
controls:0.75%
12
28
683
6912
—
—
—
—
6
13
646
6797
13
46
575
6112
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
1.6e+00
—
—
—
—
—
2.6e+00
cases:1.15%
controls:0.24%
—
—
—
—
—
—
—
—
—
—
cases:1.87%
controls:0.15%
8
17
687
6923
—
—
—
—
—
11
9
577
6149
Hepatitis B virus core Ab [Presence] in Serum
16933-4 [3021879]
4.3e-01
2.6e+00
—
—
—
—
1.1e+00
cases:1.15%
controls:0.75%
cases:1.29%
controls:0.10%
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.50%
8
52
687
6888
9
7
686
6933
—
—
—
—
9
31
579
6127
Chronic kidney disease
N18 [45582391]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.08%
—
—
—
—
—
—
6
5
582
6153
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
8.1e-01
1.3e+00
—
—
1.8e+00
1.5e+00
1.0e+00
cases:1.73%
controls:0.78%
cases:1.44%
controls:0.39%
—
—
—
—
cases:0.89%
controls:0.14%
cases:1.53%
controls:0.35%
cases:3.23%
controls:1.17%
12
54
683
6886
10
27
685
6913
—
—
6
10
669
6921
10
24
642
6786
19
72
569
6086
Epicardial ultrasonography
XFE00 [2001303343]
2.5e+00
—
—
—
—
—
—
cases:1.58%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
—
—
11
9
684
6931
—
—
—
—
—
—
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
1.6e+00
—
—
—
—
—
2.5e+00
cases:0.72%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.19%
controls:0.10%
5
10
690
6930
—
—
—
—
—
7
6
581
6152
Severe anaemia associated with chronic renal failure
138 [2001600134]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.19%
controls:0.10%
—
—
—
—
—
—
7
6
581
6152
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
5.2e-01
8.3e-01
1.4e+00
—
1.8e+00
5.1e-01
6.9e-01
cases:3.31%
controls:1.99%
cases:2.45%
controls:1.08%
cases:0.72%
controls:0.19%
—
—
cases:1.48%
controls:0.25%
cases:1.84%
controls:1.12%
cases:6.80%
controls:3.54%
23
138
672
6802
17
75
678
6865
5
13
690
6927
—
10
17
665
6914
12
76
640
6734
40
218
548
5940
Other chronic renal failure
N18.8 [45534123]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.53%
controls:0.13%
—
—
—
—
—
—
9
8
579
6150
Immunoglobulin light chains.free panel - Serum
57778-3 [40760888]
1.3e+00
2.5e+00
—
—
—
—
—
cases:0.72%
controls:0.20%
cases:1.01%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
5
14
690
6926
7
6
688
6934
—
—
—
—
—
Respiratory and circulatory monitoring
WX700 [2001310817]
9.2e-01
1.2e+00
—
1.0e+50
—
1.2e+00
1.5e+00
cases:3.60%
controls:1.47%
cases:1.58%
controls:0.46%
—
—
cases:1.15%
controls:0.00%
—
—
cases:1.84%
controls:0.57%
cases:6.12%
controls:1.48%
25
102
670
6838
11
32
684
6908
—
8
0
687
6940
—
12
39
640
6771
36
91
552
6067
cycloSPORINE [Mass/volume] in Blood
3520-4 [3010375]
-1.0e+50
—
—
—
—
—
2.4e+00
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.08%
0
5
695
6935
—
—
—
—
—
5
5
583
6153
Varicose veins of lower extremities with inflammation
I83.1 [45581827]
-1.0e+50
—
—
—
—
—
2.4e+00
cases:0.00%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.08%
0
14
695
6926
—
—
—
—
—
5
5
583
6153
Systemic involvement of connective tissue, unspecified
M35.9 [45553174]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.08%
—
—
—
—
—
—
5
5
583
6153
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 [3012477]
—
—
—
—
—
—
2.4e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.08%
—
—
—
—
—
—
5
5
583
6153
Fever, unspecified
R50.9 [45582716]
7.2e-01
1.4e+00
—
—
—
7.8e-01
9.4e-01
cases:1.73%
controls:0.85%
cases:1.58%
controls:0.39%
—
—
—
—
—
—
cases:0.92%
controls:0.43%
cases:3.06%
controls:1.22%
12
59
683
6881
11
27
684
6913
—
—
—
6
29
646
6781
18
75
570
6083
Cystatin C [Mass/volume] in Serum or Plasma
33863-2 [3030366]
1.0e+00
—
—
—
—
2.4e+00
1.3e+00
cases:0.86%
controls:0.32%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.09%
cases:1.53%
controls:0.44%
6
22
689
6918
—
—
—
—
6
6
646
6804
9
27
579
6131
Chronic ischaemic heart disease, unspecified
I25.9 [45552784]
1.2e+00
1.4e+00
—
—
—
—
1.1e+00
cases:1.87%
controls:0.55%
cases:1.29%
controls:0.32%
—
—
—
—
—
—
—
—
cases:3.06%
controls:1.06%
13
38
682
6902
9
22
686
6918
—
—
—
—
18
65
570
6093
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
1.9e-01
3.8e-01
6.6e-01
-1.0e+50
8.6e-01
5.7e-01
5.1e-01
cases:26.47%
controls:22.94%
cases:16.98%
controls:12.29%
cases:4.46%
controls:2.36%
cases:0.00%
controls:0.10%
cases:4.89%
controls:2.14%
cases:20.86%
controls:12.97%
cases:42.52%
controls:30.84%
184
1592
511
5348
118
853
577
6087
31
164
664
6776
0
7
695
6933
33
148
642
6783
136
883
516
5927
250
1899
338
4259
Pediatric Cardiology
OMOP4821938 [45756805]
2.3e+00
—
—
—
—
—
—
cases:1.15%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
8
8
687
6932
—
—
—
—
—
—
Pleural effusion, not elsewhere classified
J90 [45605897]
—
2.3e+00
—
—
—
—
1.4e+00
—
—
cases:0.86%
controls:0.09%
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.21%
—
6
6
689
6934
—
—
—
—
5
13
583
6145
Cathetrisation of pulmonal artery
TFB00 [2001302495]
2.3e+00
—
—
—
—
—
—
cases:0.86%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
6
6
689
6934
—
—
—
—
—
—
Transplant complication
127 [2001600125]
2.3e+00
—
—
—
—
1.0e+50
—
cases:0.86%
controls:0.09%
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.00%
—
—
6
6
689
6934
—
—
—
—
7
0
645
6810
—
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
—
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.18%
—
—
—
—
—
—
10
11
578
6147
Osmolality of Urine
2695-5 [3026782]
3.2e-01
2.7e-01
—
—
2.2e+00
5.2e-01
5.5e-01
cases:3.60%
controls:2.64%
cases:1.29%
controls:0.99%
—
—
—
—
cases:1.48%
controls:0.16%
cases:1.84%
controls:1.10%
cases:5.27%
controls:3.10%
25
183
670
6757
9
69
686
6871
—
—
10
11
665
6920
12
75
640
6735
31
191
557
5967
Heart disease other
K84 [2002000611]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.15%
—
—
—
—
—
—
8
9
580
6149
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
7.6e-01
2.2e+00
—
—
1.0e+50
1.5e+00
5.0e-01
cases:1.01%
controls:0.48%
cases:1.58%
controls:0.17%
—
—
—
—
cases:0.74%
controls:0.00%
cases:1.07%
controls:0.23%
cases:1.36%
controls:0.83%
7
33
688
6907
11
12
684
6928
—
—
5
0
670
6931
7
16
645
6794
8
51
580
6107
Thoracic aortic aneurysm, without mention of rupture
I71.2 [45601082]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.11%
—
—
—
—
—
—
6
7
582
6151
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
1.2e+00
—
—
—
—
2.2e+00
1.2e+00
cases:0.86%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.92%
controls:0.10%
cases:1.36%
controls:0.41%
6
18
689
6922
—
—
—
—
6
7
646
6803
8
25
580
6133
Bacteria identified in Isolate by Culture
43409-2 [3042936]
4.3e-01
1.3e+00
—
—
—
1.0e+00
8.8e-01
cases:2.01%
controls:1.33%
cases:1.58%
controls:0.43%
—
—
—
—
—
—
cases:1.38%
controls:0.50%
cases:3.91%
controls:1.66%
14
92
681
6848
11
30
684
6910
—
—
—
9
34
643
6776
23
102
565
6056
Difficulties in perfomrming procedure
ZXD30 [2001311389]
1.2e+00
—
—
—
—
—
2.2e+00
cases:1.01%
controls:0.30%
—
—
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.19%
7
21
688
6919
—
—
—
—
—
10
12
578
6146
Gastroenterology
10 [38004455]
4.9e-01
1.2e+00
—
—
1.3e+00
9.9e-01
4.6e-01
cases:5.18%
controls:3.23%
cases:4.17%
controls:1.31%
—
—
—
—
cases:0.89%
controls:0.25%
cases:3.37%
controls:1.28%
cases:6.29%
controls:4.08%
36
224
659
6716
29
91
666
6849
—
—
6
17
669
6914
22
87
630
6723
37
251
551
5907
Asthma, unspecified
J45.9 [45562456]
5.7e-01
6.1e-01
—
1.0e+50
1.6e+00
1.3e+00
9.1e-01
cases:3.31%
controls:1.90%
cases:1.87%
controls:1.02%
—
—
cases:0.72%
controls:0.00%
cases:0.74%
controls:0.14%
cases:2.61%
controls:0.75%
cases:5.78%
controls:2.42%
23
132
672
6808
13
71
682
6869
—
5
0
690
6940
5
10
670
6921
17
51
635
6759
34
149
554
6009
formoterol and fluticasone
R03AK11 [44819166]
2.2e+00
—
—
—
—
—
—
cases:0.86%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
6
7
689
6933
—
—
—
—
—
—
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.24%
—
—
—
—
—
—
12
15
576
6143
Angina pectoris, unspecified
I20.90 [2000502402]
2.1e+00
2.3e+00
—
—
—
—
—
cases:1.44%
controls:0.17%
cases:0.72%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
10
12
685
6928
5
5
690
6935
—
—
—
—
—
hydrochlorothiazide; oral
C03AA03 [21601466]
1.2e+00
8.7e-01
—
—
8.7e-01
8.8e-01
9.6e-01
cases:5.90%
controls:1.93%
cases:2.73%
controls:1.17%
—
—
—
—
cases:0.89%
controls:0.38%
cases:2.76%
controls:1.16%
cases:5.44%
controls:2.16%
41
134
654
6806
19
81
676
6859
—
—
6
26
669
6905
18
79
634
6731
32
133
556
6025
nebivolol; oral
C07AB12 [21601694]
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.07%
controls:0.13%
—
—
—
—
—
—
—
7
9
645
6801
—
Iron deficiency anaemia secondary to blood loss (chronic)
D50.0 [45566697]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.21%
—
—
—
—
—
—
10
13
578
6145
Body temperature
8310-5 [3020891]
1.1e+00
2.1e+00
—
—
—
—
7.2e-01
cases:0.72%
controls:0.23%
cases:1.15%
controls:0.14%
—
—
—
—
—
—
—
—
cases:1.19%
controls:0.58%
5
16
690
6924
8
10
687
6930
—
—
—
—
7
36
581
6122
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
-6.4e-02
4.0e-01
-1.0e+50
—
2.1e+00
2.8e-01
4.4e-01
cases:2.30%
controls:2.45%
cases:1.44%
controls:0.97%
cases:0.00%
controls:0.13%
—
—
cases:1.04%
controls:0.13%
cases:1.38%
controls:1.04%
cases:4.08%
controls:2.66%
16
170
679
6770
10
67
685
6873
0
9
695
6931
—
7
9
668
6922
9
71
643
6739
24
164
564
5994
Ultrsound examination of soft tissue not elsewhere classified
QX2XE [2001310033]
-1.0e+50
—
—
—
—
—
2.1e+00
cases:0.00%
controls:0.07%
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.13%
0
5
695
6935
—
—
—
—
—
6
8
582
6150
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
—
—
—
—
—
—
2.1e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.13%
—
—
—
—
—
—
6
8
582
6150
dalteparin; parenteral
B01AB04 [21600975]
5.8e-01
—
—
—
—
2.0e+00
1.3e+00
cases:0.72%
controls:0.40%
—
—
—
—
—
—
—
—
cases:1.23%
controls:0.16%
cases:1.02%
controls:0.28%
5
28
690
6912
—
—
—
—
8
11
644
6799
6
17
582
6141
glimepiride; oral
A10BB12 [21600761]
8.7e-01
9.4e-01
—
—
1.4e+00
8.9e-01
1.2e+00
cases:2.88%
controls:1.22%
cases:2.16%
controls:0.85%
—
—
—
—
cases:1.04%
controls:0.26%
cases:1.84%
controls:0.76%
cases:3.40%
controls:1.09%
20
85
675
6855
15
59
680
6881
—
—
7
18
668
6913
12
52
640
6758
20
67
568
6091
Thoracic Surgery (Cardiothoracic Vascular Surgery) Physician
208G00000X [38004023]
8.8e-01
—
—
—
—
—
2.0e+00
cases:0.86%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:1.70%
controls:0.23%
6
25
689
6915
—
—
—
—
—
10
14
578
6144
IgM [Mass/volume] in Serum or Plasma
2472-9 [3028026]
7.8e-01
2.0e+00
—
—
—
1.3e+00
6.3e-01
cases:1.15%
controls:0.53%
cases:1.29%
controls:0.17%
—
—
—
—
—
—
cases:0.77%
controls:0.22%
cases:1.36%
controls:0.73%
8
37
687
6903
9
12
686
6928
—
—
—
5
15
647
6795
8
45
580
6113
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
9.2e-01
1.3e+00
—
—
—
2.0e+00
3.4e-01
cases:1.58%
controls:0.63%
cases:1.01%
controls:0.29%
—
—
—
—
—
—
cases:1.53%
controls:0.21%
cases:1.02%
controls:0.73%
11
44
684
6896
7
20
688
6920
—
—
—
10
14
642
6796
6
45
582
6113
Puncture of pleura with ultrasound guidance
GA4YT [2001303531]
2.0e+00
—
—
—
—
—
1.8e+00
cases:0.86%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
cases:0.85%
controls:0.15%
6
8
689
6932
—
—
—
—
—
5
9
583
6149
Diffusion capacity of lung
54715006 [4182985]
2.0e+00
—
—
—
—
—
—
cases:0.86%
controls:0.12%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
689
6932
—
—
—
—
—
—
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
8.9e-01
4.8e-01
2.0e+00
—
—
1.1e+00
9.0e-01
cases:1.87%
controls:0.78%
cases:0.72%
controls:0.45%
cases:0.86%
controls:0.12%
—
—
—
—
cases:0.92%
controls:0.29%
cases:2.72%
controls:1.12%
13
54
682
6886
5
31
690
6909
6
8
689
6932
—
—
6
20
646
6790
16
69
572
6089

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
536
1380
12.02
237.16
10.7
1.8
2351.08
505.97
ng/l
16.78
519
1127
254
741
4.73
81.57
4.6
2.2
21.11
23.79
%
2.64
246
690
275
863
4.52
80.15
4.5
2.2
12.49
13.68
umol/l
1.96
262
798
260
809
4.45
76.13
4.5
2.2
2.33
2.31
g/l
0.19
248
745
170
387
5.43
73.00
5.5
1.9
29.97
5.87
ug/l
5.21
159
334
480
2555
3.59
59.19
43.2
6.0
1.61
1.09
inr
43.26
414
2049
258
1020
3.37
50.16
8.8
2.8
651.52
436.64
ng/l
0.42
253
787
237
945
3.24
44.70
10.9
3.4
0.81
0.82
mmol/l
0.11
230
885
392
2100
2.88
42.94
8.9
2.8
83.52
78.78
ng/l
0.05
332
1536
209
818
3.18
40.15
5.6
1.9
32.00
28.68
s
8.92
203
802
105
268
4.41
38.04
4.9
3.6
4.00
4.62
pmol/l
7.76
100
242
140
480
3.37
32.94
20.2
7.4
—
—
—
0
0
287
1457
2.60
32.74
3.7
2.1
3.25
2.83
mg/l
1.53
256
1228
181
746
2.90
30.86
11.8
5.0
1.10
1.00
mmol/l
3.62
167
694
81
198
4.48
30.83
5.0
1.8
22.61
20.61
s
1.09
76
181
137
482
3.27
30.78
2.3
3.1
64.64
67.40
g/l
4.00
130
444
90
243
4.09
30.05
1.9
1.8
1.62
1.48
g/l
0.63
79
211
158
618
2.99
29.52
16.2
7.0
-0.22
0.71
mmol/l
1.66
138
507
145
541
3.10
29.43
6.6
2.9
7.37
7.38
ph
0.94
85
303
143
530
3.11
29.35
6.6
2.9
1.17
1.96
mmol/l
1.93
129
450
159
628
2.96
29.16
16.6
6.9
4.90
5.12
kpa
1.59
153
604
159
628
2.96
29.16
16.5
6.9
11.78
12.80
kpa
1.74
154
605
157
623
2.94
28.50
16.4
7.0
7.42
7.41
ph
0.58
76
329
36
45
8.37
27.08
1.6
1.3
12423.00
133578.67
e6/l
1.11
21
24
292
1629
2.33
25.73
6.7
3.8
—
—
—
0
0
36
48
7.84
25.67
1.6
1.3
673.80
22235.43
e6/l
0.53
25
30
176
785
2.64
25.27
16.6
6.2
103.92
104.06
mmol/l
0.13
176
785
392
2490
2.25
25.05
4.9
2.7
151.42
148.46
ug/l
0.08
371
2285
35
47
7.77
24.80
1.5
1.3
—
—
—
0
0
305
1779
2.23
23.69
4.3
2.1
236.81
208.08
u/l
0.22
294
1680
132
529
2.83
23.20
18.6
7.7
119.19
122.31
g/l
0.80
132
514
149
648
2.63
22.28
2.9
2.5
1.85
1.77
%
0.32
139
574
31
15
21.52
21.41
4.3
3.1
—
—
—
0
0
32
48
6.93
20.55
1.5
1.6
—
—
—
0
0
40
76
5.51
20.35
1.5
1.1
2.44
2.67
u/ml
0.13
27
33
28
37
7.83
20.07
1.3
1.3
—
—
—
0
0
50
117
4.52
20.00
4.1
1.8
10.89
11.33
mg/l
0.12
43
110
396
2673
2.06
19.94
19.4
10.1
0.00
0.00
e9/l
0.43
330
2167
33
54
6.35
19.53
2.7
2.1
—
—
—
0
0
441
3140
2.03
18.64
12.0
7.2
14.49
11.32
umol/l
6.95
428
2984
403
2794
1.99
18.20
15.4
5.5
1.20
1.21
mmol/l
5.30
386
2550
481
3555
2.05
18.03
12.3
4.2
6.86
6.71
mmol/l
0.72
461
3364
298
1867
2.01
17.93
7.7
3.8
7.39
7.40
ph
0.74
227
1319
435
3127
1.98
17.35
15.0
6.2
1.20
1.22
mmol/l
6.20
380
2664
35
69
5.28
17.09
1.4
1.2
—
—
—
0
0
305
1967
1.95
16.54
11.4
6.0
—
—
—
0
0
414
2961
1.93
16.37
11.8
6.1
0.62
0.59
e9/l
1.85
362
2478
44
109
4.23
16.36
1.8
1.4
—
—
—
0
0
136
648
2.35
16.36
2.3
1.6
—
—
—
0
0
127
589
2.40
16.23
2.3
2.4
0.19
0.21
g/l
2.85
117
560
425
3076
1.92
16.10
12.3
6.3
0.19
0.20
e9/l
0.48
379
2627
414
2971
1.92
16.10
11.8
6.1
0.04
0.04
e9/l
0.38
361
2489
249
1516
1.98
15.84
3.7
2.6
394.84
343.12
umol/l
9.68
225
1316
204
1176
2.02
15.03
6.5
1.6
1.52
1.46
mg/l
0.07
156
936
415
3025
1.87
14.91
11.9
6.2
1.71
1.95
e9/l
3.91
367
2609
140
702
2.23
14.83
2.5
3.0
8.92
8.49
umol/l
0.13
128
636
155
812
2.16
14.71
2.9
2.0
—
—
—
0
0
382
2727
1.85
14.53
6.2
4.8
34.90
35.78
g/l
2.27
365
2547
293
1931
1.87
14.36
3.5
3.5
51.20
32.30
u/l
0.93
276
1819
40
102
4.09
14.32
1.8
1.2
360.84
243.20
u/ml
1.36
31
60
29
57
5.26
14.21
2.1
2.6
20.54
32.84
iu/ml
—
5
8
446
3374
1.83
13.71
13.8
10.2
4.36
4.07
e9/l
2.08
392
2890
39
101
4.02
13.68
1.8
1.4
148.44
159.48
au/ml
—
9
26
27
52
5.35
13.52
1.0
1.2
—
—
—
0
0
379
2738
1.80
13.50
12.2
6.2
2.70
2.94
%
1.47
360
2533
250
1591
1.87
13.50
7.0
3.8
71.73
92.97
%
21.24
244
1562
379
2739
1.80
13.47
12.4
6.3
9.08
8.98
%
0.29
360
2536
379
2746
1.80
13.29
12.2
6.3
0.66
0.69
%
0.48
360
2531
38
99
4.00
13.22
7.8
3.4
—
—
—
0
0
92
404
2.46
13.14
2.0
2.6
—
—
—
0
0
77
313
2.63
12.91
25.2
9.4
15.36
16.00
%
1.24
77
296
57
197
3.05
12.90
3.0
3.8
55.30
40.86
mg/l
0.47
51
171
57
197
3.05
12.90
3.0
3.8
42.33
108.38
mg/l
0.59
51
172
105
497
2.30
12.67
2.5
2.5
74.63
67.35
e9/l
0.81
72
360
382
2804
1.76
12.55
12.3
6.2
23.75
27.82
%
11.38
363
2633
58
209
2.93
12.20
1.6
2.8
9.75
10.92
g/l
1.21
52
186
267
1779
1.79
12.15
3.9
3.1
0.42
0.44
e6/l
0.07
209
1313
24
46
5.36
12.08
2.5
1.6
9.98
10.92
%
0.48
24
46
22
21
10.77
11.82
1.1
1.1
7.40
7.36
ph
0.20
13
15
26
55
4.87
11.73
1.1
1.3
—
—
—
0
0
372
2748
1.73
11.62
12.2
6.2
61.29
56.96
%
10.48
360
2606
295
2045
1.75
11.57
4.2
3.2
84.79
99.79
e6/l
0.15
238
1576
51
180
2.97
11.14
2.8
3.7
17.79
4.08
ratio
0.38
27
110
285
1984
1.72
10.84
3.4
2.4
—
—
—
0
0
216
1400
1.77
10.52
3.2
2.5
4.53
4.51
e6/l
0.01
201
1272
32
88
3.76
10.35
10.0
3.7
2.94
1.91
mmol/l
0.94
22
59
44
151
3.04
10.09
1.5
1.4
1.19
1.17
g/l
0.12
39
145
81
378
2.29
10.05
1.6
1.5
—
—
—
0
0
315
2289
1.66
9.97
5.0
3.8
42.81
102.30
e6/l
1.64
241
1625
31
86
3.72
9.91
2.3
2.4
—
—
—
0
0
23
51
4.62
9.83
10.0
3.4
11.88
11.50
index
0.10
17
30
261
1812
1.69
9.80
10.4
6.4
—
—
—
0
0
39
128
3.16
9.65
2.5
3.9
—
—
—
0
0
107
573
2.02
9.34
2.2
1.5
—
—
—
0
0
42
147
2.97
9.32
7.6
3.2
2.30
2.18
index
0.05
27
78
16
14
11.66
9.10
1.1
1.2
—
—
—
0
0
16
14
11.66
9.10
1.1
1.0
—
—
—
0
0
546
4645
1.71
8.72
14.3
8.3
82.58
80.42
u/l
0.26
528
4355
41
148
2.88
8.63
1.5
1.4
0.23
0.23
g/l
0.08
36
142
35
117
3.09
8.42
4.3
2.2
123.76
131.09
g/l
0.91
29
92
187
1230
1.70
8.38
2.9
2.7
521.69
566.48
mosm/kgh2o
2.28
167
1069
44
169
2.71
8.26
1.7
1.2
—
—
—
0
0
362
2814
1.57
8.15
3.6
2.7
—
—
estimate
—
0
0
39
143
2.83
7.99
5.6
3.6
4.05
3.89
mmol/l
1.17
39
143
171
1119
1.69
7.74
3.5
2.9
1.02
1.03
e6/l
0.01
86
610
256
1863
1.58
7.52
3.5
2.6
57.14
61.67
u/l
0.53
242
1712
470
3923
1.56
7.39
6.0
4.5
37.83
1994.52
e6/l
1.59
12
56
129
791
1.77
7.35
2.2
1.7
—
—
—
0
0
48
206
2.42
7.21
1.3
1.2
—
—
—
0
0
71
360
2.08
7.16
2.0
1.8
1.34
1.58
g/l
0.35
64
334
118
712
1.78
7.09
1.3
1.3
344.00
525.30
titre
1.09
20
151
158
1038
1.67
6.98
3.5
3.0
2.60
1.97
e6/l
0.42
71
527
34
125
2.80
6.95
1.3
1.1
—
—
—
0
0
72
372
2.04
6.91
5.5
3.2
7.41
7.42
ph
0.64
63
310
283
2147
1.52
6.73
4.4
3.7
2.35
2.36
mmol/l
0.42
256
1932
90
509
1.88
6.65
2.6
2.3
435.70
373.72
nmol/l
0.93
84
482
12
12
10.14
6.55
1.8
1.2
34.58
28.17
s
1.36
12
12
17
30
5.78
6.48
12.2
3.6
1.18
0.93
index
0.59
17
30
113
693
1.75
6.40
2.2
1.5
—
—
—
0
0
243
1802
1.52
6.35
2.0
1.6
20.02
20.45
nmol/l
0.16
217
1495
80
444
1.90
6.26
2.3
2.8
10.50
11.04
g/l
0.56
73
410
6
0
+∞
6.26
2.2
0.0
—
—
—
0
0
548
4813
1.57
6.20
41.8
17.8
14.15
13.60
%
12.80
541
4740
12
15
8.11
5.85
1.1
1.0
179.67
136.55
iu/ml
0.39
12
15
93
564
1.74
5.46
1.8
1.6
—
—
—
0
0
26
97
2.74
5.22
1.3
1.8
0.59
0.80
g/l
0.44
19
79
24
86
2.85
5.19
3.6
3.1
3.68
4.12
e9/l
0.55
24
86
16
46
3.53
4.91
1.3
1.1
—
—
—
0
0
15
42
3.63
4.78
1.3
1.1
—
—
—
0
0
11
17
6.55
4.78
1.7
3.1
0.63
0.59
mmol/l
0.61
11
17
92
583
1.66
4.61
3.0
2.4
297.93
36.99
u/l
0.51
80
486
76
458
1.74
4.57
4.1
3.5
—
—
—
0
0
20
70
2.91
4.52
1.5
1.5
—
—
—
0
0
20
70
2.91
4.52
1.5
1.5
—
—
—
0
0
20
70
2.91
4.52
1.5
1.5
—
—
—
0
0
20
70
2.91
4.52
1.5
1.5
—
—
—
0
0
168
1239
1.46
4.28
8.7
4.8
—
—
—
0
0
29
127
2.34
4.25
1.6
1.7
2.53
4.27
iu/l
—
10
51
266
2147
1.38
4.04
3.5
3.4
77.78
37.03
mg/l
1.47
194
1349
275
2237
1.37
3.96
3.4
3.3
7.35
7.91
mmol/l
1.43
223
1881
620
5757
1.53
3.94
34.9
13.9
27.07
27.13
mg/l
0.01
543
4637
154
1137
1.45
3.88
1.6
1.5
2.67
2.63
g/l
0.08
97
646
26
114
2.33
3.82
4.7
2.8
58.07
58.07
%
0.00
26
114
11
24
4.64
3.75
8.4
1.9
705.27
1845.58
u/ml
0.60
11
24
489
4368
1.37
3.74
5.4
3.9
15.40
14.87
pmol/l
4.42
466
3918
80
517
1.62
3.72
5.7
5.2
0.32
0.07
%
0.42
25
134
25
109
2.34
3.72
1.2
1.5
16.92
30.50
u/l
0.58
19
91
27
122
2.26
3.71
2.0
1.7
—
—
—
0
0
12
30
4.05
3.60
1.1
1.3
—
—
—
0
0
117
831
1.49
3.58
1.2
1.2
—
—
—
0
0
267
2191
1.35
3.55
4.3
4.0
14.24
5.57
mg/mmol
1.63
184
1348
74
476
1.62
3.52
6.0
3.9
1.21
1.23
mmol/l
1.44
63
404
78
509
1.60
3.50
5.2
4.7
0.24
0.61
%
2.21
27
157
56
340
1.70
3.33
1.4
1.6
—
—
—
0
0
368
3192
1.31
3.23
4.7
3.7
0.05
0.01
estimate
0.43
86
626
363
3143
1.31
3.22
4.7
3.7
0.00
0.00
estimate
-0.00
95
662
22
99
2.26
3.09
4.3
3.0
11.10
7.74
pmol/l
0.83
22
99
5
5
10.06
2.98
1.8
5.6
4.10
5.26
kpa
—
5
5
364
3181
1.29
2.91
4.8
3.8
0.00
7.73
estimate
1.08
95
679
78
538
1.50
2.77
5.7
4.7
0.48
0.98
%
1.68
27
170
97
700
1.45
2.75
1.8
1.5
—
—
—
0
0
75
514
1.51
2.74
5.7
4.9
0.04
0.11
%
0.71
24
149
17
72
2.39
2.74
1.2
1.3
0.70
25.98
nmol/l
0.49
17
67
214
1758
1.31
2.70
3.5
3.1
—
—
—
0
0
12
43
2.82
2.65
1.0
1.0
—
—
—
0
0
83
591
1.46
2.53
2.8
1.3
—
—
—
0
0
291
2507
1.27
2.50
4.4
3.3
6.30
6.24
ph
0.39
158
1393
15
63
2.41
2.47
1.1
1.1
—
—
—
0
0
213
1767
1.29
2.47
5.1
3.8
0.00
0.01
estimate
0.69
85
611
24
125
1.95
2.38
1.2
1.1
—
—
—
0
0
325
2849
1.25
2.37
2.3
2.1
93.16
94.46
pmol/l
0.20
168
1478
39
240
1.66
2.27
1.5
1.6
0.40
0.36
mg/l
0.09
16
117
15
66
2.30
2.25
1.2
1.2
—
—
—
0
0
12
48
2.53
2.19
1.2
1.2
—
—
—
0
0
8
24
3.36
2.18
1.1
1.0
—
—
—
0
0
17
81
2.13
2.14
2.3
2.2
—
—
—
0
0
12
49
2.47
2.11
1.0
1.0
—
—
—
0
0
24
131
1.86
2.10
1.3
1.3
247.00
250.75
miu/ml
—
6
56
6
15
4.02
2.04
3.0
1.7
—
—
—
0
0
36
225
1.63
2.00
1.7
1.7
16.86
7.61
iu/ml
—
7
57
7
21
3.36
1.97
6.1
4.8
8.16
6.86
mmol/l
—
7
21
129
1033
1.30
1.94
1.9
1.7
1382.13
1123.69
nmol/l
2.16
101
765
13
58
2.26
1.91
2.1
2.4
2.42
0.69
g/24h
—
8
33
276
2422
1.23
1.89
2.1
2.2
—
—
—
0
0
156
1286
1.27
1.87
2.9
3.1
2.46
2.45
mmol/l
0.31
138
1163
199
1689
1.25
1.86
1.4
1.4
—
—
—
0
0
302
2688
1.21
1.77
3.3
2.3
76.40
78.71
nmol/l
0.76
273
2369
12
54
2.24
1.74
1.5
1.3
—
—
—
0
0
12
55
2.20
1.68
1.5
1.3
6.30
6.93
g/l
—
7
41
564
5351
1.24
1.66
6.5
4.9
2.11
1.94
mu/l
2.30
538
4817
7
25
2.82
1.65
3.1
2.6
1537.14
1604.50
ml
—
7
20
32
206
1.58
1.62
2.4
4.0
249.90
188.39
mg/l
0.38
21
93
5
14
3.59
1.62
4.8
2.6
—
—
—
0
0
191
1638
1.23
1.61
3.2
3.0
0.00
0.06
—
6
47
6
20
3.02
1.58
7.2
5.0
17.13
16.54
%
—
6
20
24
381
0.62
1.54
1.7
1.7
3.09
3.47
mmol/l
0.92
18
280
5
15
3.35
1.52
1.0
1.8
—
—
—
0
0
41
284
1.47
1.51
5.8
3.2
—
—
—
0
0
11
52
2.13
1.45
1.1
2.3
—
—
—
0
0
14
73
1.94
1.44
1.4
1.5
28.29
29.15
ng/l
0.04
14
73
6
22
2.74
1.43
1.0
1.1
—
—
—
0
0
632
6103
1.27
1.40
48.3
16.2
139.20
139.72
mmol/l
4.25
620
5954
10
46
2.19
1.40
1.4
2.1
970.60
694.33
mg
—
10
46
13
67
1.96
1.39
1.2
1.3
—
—
nmol/l
—
0
0
575
5500
1.22
1.37
5.7
4.3
1.34
1.30
mmol/l
0.75
540
4976
9
41
2.21
1.37
2.0
2.0
43.28
37.80
%
—
9
41
8
164
0.48
1.37
1.1
1.2
1.01
0.90
g/l
—
8
164
10
47
2.14
1.34
1.1
1.5
—
—
—
0
0
9
42
2.16
1.34
1.6
1.4
82.78
83.05
umol/l
—
9
42
632
6114
1.26
1.30
48.9
16.3
4.04
3.98
mmol/l
7.62
619
5953
141
1646
0.82
1.30
3.3
3.3
0.57
0.75
ug/l
3.15
93
1115
34
235
1.47
1.29
1.4
1.3
—
—
—
0
0
620
5986
1.24
1.29
28.2
12.6
—
—
—
0
0
9
44
2.06
1.27
1.6
2.5
—
—
—
0
0
8
35
2.30
1.27
1.1
1.8
—
—
—
0
0
12
63
1.92
1.23
1.2
1.2
—
—
—
0
0
11
56
1.98
1.22
1.0
1.2
—
—
—
0
0
262
2368
1.17
1.20
4.8
3.7
0.02
0.02
estimate
0.09
88
538
232
2570
0.86
1.16
2.0
1.9
1.47
1.35
mmol/l
0.91
172
2132
8
39
2.06
1.15
1.1
1.1
111.00
115.15
pmol/l
—
8
39
8
153
0.52
1.15
1.1
1.2
1.41
1.51
g/l
—
8
153
10
51
1.97
1.11
3.8
2.5
44.60
34.75
mg/l
—
10
32
16
96
1.68
1.11
1.0
1.1
—
—
—
0
0
56
711
0.77
1.09
2.3
2.3
89.68
119.45
ug/g
0.92
42
555
21
139
1.53
1.01
2.0
2.3
16.64
73.16
ug/min
2.19
11
83
149
1306
1.18
0.99
1.3
1.2
0.93
1.21
u/ml
0.53
38
329
194
2151
0.87
0.96
3.6
3.2
—
—
—
0
0
13
77
1.70
0.95
1.6
2.4
185.13
3990.48
u/l
—
6
27
100
849
1.21
0.95
1.3
1.3
—
—
—
0
0
245
2671
0.88
0.95
5.5
5.7
2.35
2.60
ug/l
0.28
213
2421
16
101
1.60
0.94
1.0
1.1
—
—
—
0
0
578
5593
1.16
0.90
7.6
6.5
40.96
39.42
mmol/mol
3.68
540
5170
33
433
0.75
0.85
1.2
1.5
—
—
—
0
0
64
526
1.24
0.85
3.1
2.4
0.47
0.32
e6/l
0.36
64
501
83
702
1.21
0.84
1.4
1.4
—
—
—
0
0
36
276
1.32
0.82
1.4
1.2
—
—
—
0
0
40
316
1.28
0.75
1.2
1.1
168.11
115.96
u/ml
0.21
14
114
153
1375
1.14
0.75
5.6
3.9
1.02
1.02
kg/l
0.94
109
899
22
300
0.73
0.74
1.8
1.8
—
—
—
0
0
9
56
1.61
0.72
1.0
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
5
27
1.86
0.68
1.0
1.1
—
—
—
0
0
22
164
1.35
0.63
1.0
1.1
—
—
—
0
0
14
199
0.70
0.62
1.1
1.2
—
—
—
0
0
21
156
1.36
0.61
1.5
1.7
9750.79
14353.97
e6/l
0.33
14
103
110
983
1.14
0.60
1.4
1.3
38.32
37.68
iu/ml
0.02
39
298
0
22
0.00
0.59
0.0
3.3
—
34.00
—
0
16
105
937
1.14
0.59
1.2
1.3
5.01
12.58
u/ml
1.48
42
348
10
65
1.55
0.55
1.2
1.2
—
—
—
0
0
181
1676
1.11
0.55
4.2
3.2
0.00
0.00
estimate
0.80
82
537
589
5763
1.12
0.54
6.3
5.1
1.32
1.45
mmol/l
13.57
553
5274
23
293
0.78
0.53
2.7
2.3
0.00
0.01
estimate
—
10
93
63
723
0.86
0.52
3.0
4.9
6.00
24.42
ug/l
1.11
56
599
6
40
1.50
0.51
1.2
1.0
—
—
—
0
0
592
5804
1.11
0.48
6.4
5.2
4.18
4.62
mmol/l
20.70
557
5348
13
177
0.73
0.47
1.2
1.4
275.88
275.80
ug/g
—
8
99
587
5757
1.10
0.46
6.2
5.2
6.20
5.97
mmol/l
3.16
542
5195
12
163
0.73
0.44
1.0
1.1
—
—
—
0
0
55
624
0.87
0.41
6.7
3.9
7.36
7.36
ph
0.02
44
421
8
58
1.38
0.41
2.0
3.2
2.13
2.70
nmol/l
—
8
58
65
578
1.14
0.41
2.1
2.2
0.00
0.03
estimate
0.50
12
120
5
33
1.52
0.41
1.0
1.3
172.40
143.54
nmol/l
—
5
33
0
16
0.00
0.41
0.0
8.1
—
9.01
—
0
16
141
1313
1.09
0.40
1.9
1.7
111111557.70
13573828.72
pmol/l
0.65
117
1083
5
35
1.43
0.39
1.6
1.1
—
—
—
0
0
10
137
0.73
0.39
1.2
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
71
639
1.12
0.38
2.4
2.3
11.40
13.81
nmol/l
1.70
62
578
32
271
1.19
0.38
2.6
3.0
—
—
—
0
0
12
158
0.76
0.37
3.3
4.7
—
—
—
0
0
5
37
1.35
0.37
1.2
1.1
6.98
6.35
ug/l
—
5
31
10
72
1.39
0.37
1.0
1.3
—
—
—
0
0
35
303
1.16
0.33
2.4
3.6
1.02
1.02
ratio
0.64
30
280
10
74
1.36
0.32
1.4
1.7
—
—
—
0
0
634
6407
0.92
0.30
52.3
22.0
133.47
136.33
g/l
4.11
625
6299
31
356
0.87
0.30
1.1
1.4
—
62.95
—
0
35
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
391
3813
1.06
0.29
3.9
3.2
71.83
53.26
u/l
2.56
369
3539
634
6404
0.92
0.28
54.9
22.2
40.12
40.50
%
0.90
624
6292
634
6404
0.92
0.28
51.6
21.8
30.37
30.44
pg
0.38
624
6298
634
6404
0.92
0.28
51.7
21.8
91.74
91.27
fl
1.63
624
6299
634
6404
0.92
0.28
51.8
21.8
4.46
4.51
e12/l
1.36
622
6202
634
6404
0.92
0.28
52.0
21.9
7.15
6.70
e9/l
2.21
621
6204
22
257
0.85
0.26
1.5
3.8
28.77
112.73
u/ml
1.11
22
252
634
6401
0.92
0.26
51.8
21.9
232.50
247.75
e9/l
5.92
622
6224
35
310
1.14
0.26
2.3
2.3
—
—
—
0
0
5
72
0.69
0.26
1.2
1.2
—
—
—
0
0
9
76
1.19
0.24
1.3
1.1
—
—
—
0
0
25
217
1.16
0.24
1.4
1.8
41.52
38.97
nmol/l
0.24
25
208
10
126
0.79
0.24
1.1
1.2
—
—
—
0
0
627
6212
1.07
0.22
19.8
11.8
29.99
26.18
u/l
0.82
604
5991
7
91
0.77
0.22
3.0
5.9
292.43
376.21
umol/l
—
7
84
0
11
0.00
0.21
0.0
1.5
—
1.29
—
0
5
0
10
0.00
0.21
0.0
1.0
—
0.02
—
0
10
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
71.42
—
0
12
5
43
1.16
0.21
1.2
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
16.90
—
0
13
0
13
0.00
0.21
0.0
1.2
—
37.80
—
0
5
10
80
1.25
0.20
1.0
1.1
—
—
—
0
0
10
81
1.24
0.19
1.0
1.1
—
—
—
0
0
596
5908
1.05
0.17
7.2
5.9
2.40
2.71
mmol/l
15.91
560
5417
22
247
0.89
0.17
1.0
1.1
—
—
—
0
0
21
187
1.13
0.16
1.4
1.8
—
—
—
0
0
30
274
1.10
0.15
2.1
3.8
27.37
4807.65
u/ml
0.74
25
239
633
6293
1.05
0.13
47.4
18.6
95.01
78.06
umol/l
13.11
621
6197
489
4854
1.02
0.09
49.0
18.6
330.43
332.89
g/l
7.49
484
4824
72
745
0.96
0.09
3.6
3.5
4.54
5.13
e9/l
0.32
66
637
5
61
0.82
0.08
1.4
1.5
—
—
—
0
0
14
153
0.91
0.07
1.6
1.3
—
—
—
0
0
14
153
0.91
0.07
1.6
1.3
—
—
—
0
0
14
153
0.91
0.07
1.6
1.3
—
—
—
0
0
13
142
0.91
0.06
1.4
1.3
—
—
—
0
0
23
220
1.05
0.03
7.5
5.0
0.75
0.91
%
1.65
23
205
14
149
0.94
0.03
1.6
1.3
—
—
—
0
0
47
461
1.02
0.02
1.1
1.2
—
—
—
0
0
41
415
0.99
0.00
1.4
1.2
—
—
—
0
0
11
108
1.02
0.00
7.1
7.1
102.27
105.87
mmol/l
0.91
11
94
11
108
1.02
0.00
7.1
7.1
12.64
10.89
mmol/l
1.50
11
94
46
458
1.00
0.00
2.3
2.7
5.84
6.04
ph
1.04
35
311
20
201
0.99
0.00
9.6
9.2
—
—
—
0
0
7
77
0.91
0.00
3.7
2.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
6.79
—
0
6
0
5
0.00
-0.00
0.0
8.2
—
0.20
—
0
5
0
6
0.00
-0.00
0.0
1.2
—
0.38
—
0
6
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
5
59
0.85
-0.00
1.4
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.5
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint I9_CARDMYOHYP and mortality.

Females

Parameter HR [95% CI] p-value
I9_CARDMYOHYP 2.125 [1.83, 2.47] < 0.001
Birth year 0.993 [0.98, 1.0] 0.105

During the follow-up period (1.1.1998 — 31.12.2019), 446 out of 1326 females with I9_CARDMYOHYP died.

Males

Parameter HR [95% CI] p-value
I9_CARDMYOHYP 2.113 [1.81, 2.47] < 0.001
Birth year 0.988 [0.98, 1.0] 0.012

During the follow-up period (1.1.1998 — 31.12.2019), 581 out of 1732 males with I9_CARDMYOHYP died.

Mortality risk

Mortality risk for people of age

years, who have I9_CARDMYOHYP.

N-year risk Females Males
1 0.224% 0.382%
5 1.246% 2.525%
10 3.069% 6.487%
15 5.663% 11.863%
20 9.796% 20.165%

Relationships between endpoints

↥

Index endpoint: I9_CARDMYOHYP – Cardiomyopathy, Hypertrophic obstructive

GWS hits: 18

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data